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Abstract 
Acquiring long-term protective immunity involves the generation and recall 
production of high affinity antibodies by B cells in response to foreign antigen. 
This occurs only with the help of T cells. T follicular helper (Tfh) cells in 
particular are specialised in homing to B cell-enriched follicles and germinal 
centres (GCs) of secondary lymphoid organs where they provide selective 
paracrine signals to support high affinity surface immunoglobulin expression on 
mutating B cells that differentiate into long-lived plasma cells and memory B 
cells. Deregulation of Tfh cells leads to a breakdown in the negative selection of 
pathogenic GC B cell mutants that seed lymphomas or produce disease-
causing autoantibodies. It is thus in this context, for the potential to realise 
biomedical innovations, important to characterise signalling networks that 
control Tfh cell development and effector function. Here, we sought to map the 
signalling network of an incompletely understood Tfh cell immunomodulator, 
ROQUIN, encoded by the Rc3h1 locus. ROQUIN, along with its only 
mammalian paralogue, ROQUIN2 harbours a unique ROQ domain 
indispensible in RNA regulation and in preventing unrestricted Tfh cell 
accumulation that causes systemic autoimmunity. Upstream of the ROQ 
domain is the ROQUIN amino terminus containing the most evolutionarily 
conserved sequence and a predicted but uninspected RING domain associated 
with E3 ubiquitin ligase activity. To determine the putative role of this ROQUIN 
RING domain in T cell-dependent B cell immunity, we generated a novel mouse 
model (Tringless), harbouring a T cell-specific genetic deletion of Rc3h1 exon 2, 
encoding for the RING domain. In vivo analysis of Tringless mice revealed 
minimal perturbations in ROQUIN ROQ-RNA signalling but an unexpected 
requirement for T cell ROQUIN RING activity in selectively promoting Tfh cell 
! vii!
and GC responses to T-dependent antigens. The development of other effector 
T cell subsets (Th1, Th2, Th17 and Treg) was not affected. In order to identify 
potential substrates of the ROQUIN RING domain, we systematically screened 
for protein partners able to directly bind ROQUIN. Adenosine Monophosphate-
activated Protein Kinase (AMPK) was discovered to be targeted by ubiquitin-
dependent ROQUIN RING signalling, which was required to limit aberrantly high 
AMPK activity. Well established as an antagonist to mTOR metabolic signalling 
and as a central regulator of cellular bioenergetics and proliferation, AMPK 
activity has not been previously described in Tfh cells. Using an mTOR-deficient 
mutant mouse strain (chino), we confirmed mTOR as an essential pathway in 
Tfh cell formation. Consequently, we qualify ROQUIN as a bone fide RING-
driven E3 ubiquitin ligase and report a novel ROQUIN-AMPK-mTOR metabolic 
nexus that our data suggests is important in promoting Tfh cell responses.  
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 1 
chapter one 
1. Introduction 
1.1. T cell-dependent B cell immunity 
Fundamental to the adaptive immune system is its capacity to improve 
pathogen recognition and clearance after initial infection while maintaining 
immunological tolerance. This requires regulated cooperation with its various 
lymphocyte components, especially between CD4+ T cells and B cells. 
Following their priming by dendritic cells, CD4+ T cells provide stimulatory 
signals to cognate naïve B cells of primary follicles (Figure 1.1.). This occurs at 
the outer T zone or T-B border in secondary lymphoid organs and involves 
ligation of CD40 receptor on B cells by its inducible T cell surface CD40L to 
induce B cell clonal expansion and differentiation [1]. At these early stages of a 
T cell-dependent B cell immune response, T cells also release cytokines that 
direct dividing B cells to undergo immunoglobulin (Ig) class-switching [2]. T cell-
stimulated B cells are prompted to then differentiate either (i) into short-lived 
extrafollicular plasma cells that secrete low-affinity antibodies important for 
immediate defense against infection, (ii) into early memory B cells, or (iii) within 
secondary follicles to form a germinal centre (GC). 
 
GCs are dynamic multicompartmental microenvironments that provide a unique 
niche for B cell differentiation, Ig affinity maturation, and clonal selection to 
occur [3]. During a GC reaction, maturing B cell clones undergo somatic 
hypermutation to acquire random single-nucleotide changes in the Ig V-region 
genes. From this clonal diversity, GC-residing CD4+ T cells provide contact-
dependent survival signals to cognate B cells expressing greater Ig affinity 
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Figure 1.1. The T-dependent immune response  
At the T-B border, a subset of effector T cells from the T zone engage B cells of 
the primary follicle and induce their bifurcated differentiation. Some T cell-
activated B cells give rise to an immediate extrafollicular response that 
produces early plasma cells and memory B cells of low antibody affinity towards 
antigen.  Follicular B cell responses can also progress to establish a secondary 
follicle with a focal germinal centre. Transitting between the dark zone and light 
zone, germinal centre B cells continue to proliferate and mature their surface 
immunoglobulin to gain greater antigen affinity. Ultimately, B cells exit the 
germinal center differentiated into high-affinity durable plasma cells and 
memory B cells. DZ, Dark zone; EF, Extrafollicular foci; GC, Germinal center; Ig, 
Immunoglobulin; LZ, Light zone; MZ, Mantle zone; PC, Plasma cell; PF, Primary 
follicle; SF, Secondary, follicle; TB, T-B border; TZ, T zone. 
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towards immunising antigen. This eventuates in out-competition and apoptosis 
of low affinity, non-responsive and self-reactive GC B cells. Ultimately, based on 
as yet unclear signals, selected B cell clones exit the GC as either differentiated 
high affinity antibody-secreting plasma cells or memory B cells. The 
requirement for CD4+ T cells in B cell responses is not only highlighted by their 
capacity to induce GC formation but also by their role as a limiting factor in GC 
B cell selection, leading to affinity maturation of long-term antibody responses 
[4]. 
 
1.2. T follicular helper cells 
Following their priming by professional antigen presenting cells in the periphery, 
naïve CD4+ T cells can differentiate into one of several effector subsets or 
lineages specialised in advancing different arms of the immune response 
depending on immunising conditions, such as the inflammatory setting or 
cytokine milieu [5, 6]. Differentiation into T helper 1 (Th1) cells is programed by 
the nuclear factor TBET and allows Th1 production of IFN! cytokine to recruit 
macrophages and enhance CD8+ T cell cytolytic activity. Alternatively, T helper 
2 (Th2) cells are programmed by GATA3 and produce IL-4 and IL-5 to initiate 
B cell differentiation and eosinophil activation, respectively. ROR!T-driven 
T helper 17 (Th17) cells are named accordingly due to their high secretion of 
the proinflammatory cytokine IL-17, important for neutrophil chemotaxis. 
Regulatory T (Treg) cells that express the tolerogenic nuclear factor FOXP3 and 
secrete the T cell immunosuppresive IL-10 cytokine are important in limiting the 
potential for self-reactive and autoinflammatory responses. There are also 
CXCR5+PD-1+ T follicular helper (Tfh) cells identified first in human tonsils as 
the follicular B cell helper subset [7-9] and later found to be dependent on BCL6 
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for their unique capability to migrate into the B cell-enriched follicles and into 
GCs [10-12].  Prior to GC entry, Tfh cells deliver specialist help signals that 
prime B cells that have bound cognate antigen to initiate proliferation, undergo 
isotype switching and differentiate along the extrafollicular or GC pathway. 
Within GCs, Tfh cells select B cells that bind antigen with greater affinity. In 
recent years our understanding and appreciation of Tfh cell biology has greatly 
accelerated [4]. 
 
Follicular homing by developing Tfh cells is reliant upon a multi-step 
chemotactic process, initiating with the downregulation of CCR7 expression, the 
receptor for chemokines CCL12 and CCL19 produced in the T zone of 
secondary lymphoid organs [13, 14]. Escape from the T zone concurrently 
occurs with induced expression of the CXCR5 surface receptor, which facilitates 
entry to follicles and GCs by binding CXCL13 chemokine abundant in these 
B cell zones [15]. The costimulatory receptor ICOS and its affinity for ICOSL on 
follicular B cells has also been implicated in Tfh cell migration [16]. This process 
of Tfh cell B cell-homing is triggered at the transcriptional level by BCL6, the 
principal nuclear factor that directs Tfh cell differentiation [10-12]. BCL6 
transcriptionally represses Prdm1, encoding for BLIMP1 expression in activated 
CD4+ T cells, which otherwise inhibits Tfh cell differentiation [10] at least in part 
by transcriptional silencing of Cxcr5 [17]. In addition, BCL6 expression allows 
for the distinction of Tfh cells from other effector CD4+ T cells, namely Th1, Th2, 
Th17 and Treg cells [18], and also permits histological detection of Tfh cells 
outside GCs as BCL6-expressing T cells migrating through the T-B border or 
B cell follicles, and within the light zone of active GCs. Initial studies on the 
kinetics of BCL6 expression in developing Tfh cells noted that induction of BCL6 
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protein expression in activated CD4+ T cells occurs during priming by antigen 
presenting dendritic cells and independent of cognate B cells [19, 20]. BCL6 
levels in primed T cells then gradually diminish over 1 to 3 rounds of cell 
division before a second wave of BCL6 upregulation is triggered. Secondary 
signals that stabilise and potentially enhance BCL6 expression in activated 
CD4+ T cells are required for follicular entry and dedicated Tfh cell differentiation 
[19-21]. These secondary signals are largely dependent on B cell contact and 
the formation of stable T cell-B cell conjugates lasting at least more than 15 min 
in vivo [22, 23]. T cell-B cell interactions can occur at various stages of a T cell-
dependent humoral response, including at the T cell-B cell zone border pre-GC 
formation, within activated primary follicles or even later within maturing GCs. 
The absence or instability of these T cell-B cell interactions can result in a 
failure to form Tfh cells, thus precluding T-dependent GC formation [24]. 
  
1.2.1. Tfh cells coordinate GC reactions  
Tfh cells are superior to other T cell subsets in delivering support to cognate 
B cells [7-9]. At the early stages of a T-dependent response, Tfh cells play an 
immediate role in prompting follicular B cell survival and proliferation and 
commitment to form GCs. As the GC develops, Tfh cells uniquely colocalise 
with the B cells inside the GC light zone and continue to provide ongoing 
contact-dependent help as the B cells undergo dynamic differentiation which, in 
part, underlies GC B cell positive selection via binding of B cell stimulatory 
receptors by expressing signature membrane-bound ligands [4]. Analogous to 
early T cell priming of B cells at the T cell-B cell border, the expression of 
CD40L by Tfh cells and its activation of CD40 receptor on GC B cells is 
important for promoting and sustaining GC reactions as documented by Han et 
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al. [25] with the injection of neutralising anti-CD40L antibodies that disrupt the 
longevity of established GCs. The homophilic SLAM family members including 
CD84 and Ly108 have also emerged as essential adhesion molecules 
necessary for prolonged Tfh-GC B cell engagement [26]. These molecules 
expressed both on Tfh and GC B cells self-ligate with high affinity at the T-B cell 
surface interface. Interactions of SLAM family members in concert with BCR or 
CD40 activation provide stimuli via the PI3K and MAPK pathways to promote 
B cell proliferation and antibody production [27-29]. Additionally, SLAM signals 
are also transduced to Tfh cells via intracellular SAP, a critical adaptor protein in 
the Tfh cell response [24, 30]. Tfh SLAM-SAP signalling can control the 
production of IL-4 cytokine, a B cell survival and growth factor [31]. The 
secretion of B cell-helping cytokines during a protective immune response 
serves as key mode of Tfh effector function. Genetic regulation of Il4 expression 
in Tfh cells is significantly distinct from Th2 cells and its production important for 
augmenting GC responses [32, 33]. Tfh IL-4 release primarily plays a late role 
in an established GC response and is considered dispensable in the initial 
stages of Tfh cell formation [34, 35] and T cell-B cell priming [36]. This however 
is not the case for another canonical Tfh cytokine, IL-21, which appears to be 
important for early T-dependent B cell responses in immunised mice [37] as 
well as supporting GC persistence and Ig affinity maturation by binding B cell 
IL-21R leading to sustained BCL6 expression [38, 39]. IL-21 can also facilitate 
Tfh cell formation via autocrine signalling [38, 40], particularly under certain 
immunisation conditions.  
 
The nature and duration of Tfh paracrine signals delivered to B cells can 
influence the magnitude of GC responses, albeit only partially. It is thought that 
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integral to the quality and type of T-B cell signalling, the dosage of Tfh cell 
numbers can also determine GC robustness [41]. Indeed there is precedence 
from mouse studies whereby experimental depletion [10, 11, 42] or titrating 
down the quantity [43] of Tfh cells can cause a proportional reduction in GC 
B cells. Conversely, either spontaneous or immunisation-induced GC 
enhancement can be achieved by increasing Tfh cell numbers [42, 44, 45]. It is 
thus increasingly common practice in immunology research to assess the size 
the Tfh cell response as a correlative biomarker of GC activity. 
 
Tfh cells specifically residing in the GC light zone have a considerable role in 
shaping the B cell clonality of GCs [46]. Likely through the provision of 
membrane-bound ligands and cytokine instruction, GC-Tfh cells can prompt the 
light zone to dark zone transit of a target subset of centrocyte clones that both 
transiently express c-MYC and have greatest Ig affinity for antigen [47]. This 
Tfh-directed interzonal migration of positively selected B cells from the light to 
the dark zone, is termed “cyclic re-entry” [48] and coordinates affinity-matured 
GC clones to undergo further rounds of clonal expansion and selection that are 
required to produce optimal Ig affinity characteristic of long-lived plasma cells 
and memory B cells [49, 50]. Together with the capacity for T cell help to 
promote rapid cell cycle progression of positively-selected high affinity GC B 
cells [51], T-dependent cyclic re-entry thus underscores the physiological 
progressive enhancement of the antigen binding capacity of serum antibodies 
during the course of a T-dependent immune response. 
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1.2.2. Heterogeneity of Tfh cells 
It is becoming increasingly clear that Tfh cells are in fact a diverse population 
[52-55]. Multiple distinct Tfh subsets have been identified, each with significant 
functional divergence in modulating B cell responses, thus contributing to the 
heterogenous nature of T cell-derived help signals to B cells. 
 
In immunised mice, early Tfh cells at the T:B border detectable soon after T cell 
priming and pre-GC formation are termed “pre-Tfh” cells [22, 23, 37] (Figure 
1.2.). Pre-Tfh cells are considered precursors to the canonical Tfh cells found 
within GCs, also referred to as “GC-Tfh” cells. Although both cell types 
constitutively express BCL6 and CXCR5, there are various molecular nuances 
that distinguish pre-Tfh from GC-Tfh cells. CD28 signalling seems to be a 
requirement for pre-Tfh cells [42], and although it probably is not required for 
Tfh-dependent proliferation of GC B cells, [56], it is necessary to maintain 
Tfh cell numbers, and as a consequence optimal GC B cell numbers [57]. Also, 
in response to immunisation with sheep red blood cells (SRBC) and to 
Salmonella infection, pre-Tfh cells exhibit lower surface expression of PD-1 
receptor than that found on GC-Tfh cells [37]. It is thought that due to their swift 
development during a T-dependent response, pre-Tfh cells are uniquely 
capable of promoting both low-affinity extrafollicular antibody responses and 
GC reactions, both in an IL-21-dependent manner [37]. In contrast, GC-Tfh cells 
principally orchestrate GC selection by directing the cycling re-entry of high 
affinity light zone clones (previously discussed in section 1.2.1.). 
 
Further heterogeneity is observed amongst human tonsillar CXCR5+ GC-Tfh 
cells, with those located within GC internal areas showing high surface
 9 
 
Figure 1.2.  Tfh cell heterogeneity  
Multiple distinct populations of follicular T cells inhabit the GC to help or repress 
the production of high affinity memory B cells (MBC) and antibody-secreting 
plasma cells (PC). These different T cells provide signals to both follicular (Fo) 
and GC B cells at different stages of a T-dependent humoral response. Adapted 
from Ramiscal and Vinuesa [54]. 
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expression for CD57 as opposed to outer zone GC-Tfh cells that appear to be 
CD57! [8]. To date, the physiological and functional divergence between human 
CD57+ versus CD57! GC-Tfh remains uncertain. Strikingly, CD57! but not 
CD57+ GC-Tfh cells appear to contain pre-formed CD40L, which may have 
important implications in the provision of differentiation signals to B cells [58]. It 
is suggested that CD40L signals differentially promote long-lived memory B 
cells and plasma cells, favouring the former [59]. Indeed, experiments using 
tonsil grafts into immunodeficient mice have shown that CD40L-CD40 signals, 
but not T cells are dispensable for the survival of plasma cells in these human 
secondary lymphoid tissues [60]. This is consistent with observations that 
memory B cells tend to localise adjacent to GCs, with close proximity to CD57! 
GC-Tfh cells [61, 62]. Furthermore, in vitro studies have shown CD57+ GC-Tfh 
cells produce high levels of IL-10 [8], a cytokine suggested to promote plasma 
cell development [63] and limit post-GC memory B cell expansion [62]. 
Therefore, it is possible that CD57! GC-Tfh cells represent a subset specialised 
in fostering optimal GC-derived memory B cell maintenance and proliferation.  
 
In the tonsils of human patients, CD4+CD25+ Treg cells that localise to the B cell 
follicles have been shown to directly suppress GC-Tfh cells and T-dependent B 
cell responses [64, 65]. In mice, these GC-resident T follicular regulatory cells 
or “Tfr cells” are an emerging immunosuppressive Tfh subset (Figure 1.2.) that 
are strong producers of IL-10 [66], as are most Treg cells including activated 
extrathymic Tregs [67] and type 1 regulatory T (Tr1) cells [68]. Tfr cells share 
phenotypic markers with canonical GC-Tfh cells including CXCR5, PD-1, and 
BCL6, but diverge in their substantial expression of BLIMP1 and CD25 [66, 69, 
70]. In addition, Tfr cells are uniformly FOXP3+ and importantly do not express 
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B cell-helping cytokines nor CD40L. Tfr cell development can initiate with 
thymic Tregs (also called natural regulatory T cells or nTreg) or from peripheral 
naïve CD4+ T cells [71]. As occurs with their FOXP3- GC-Tfh cell counterparts, 
Tfr cell development requires the presence of B cells and intact SAP signalling, 
suggesting a requirement for SLAM-mediated intercellular interaction between 
Tregs and B cells for entry into GCs. ICOS instruction is also important for 
Tfr cells [72], which have a unique role in restricting GC reactions at least in 
part through CTLA4-dependent reduction of the costimulatoy molecules CD80 
and CD86 expressed on GC B cells [73, 74] – a process known as 
transendocytosis [75]. Absence of Tfr-mediated GC regulation can lead to 
aberrant GC expansion and systemic humoral autoimmunity [76] in mice. 
 
There are other T cells that share the GC microenvironment with Tfh cells that 
are interestingly not restricted to MHC class II presented peptides. Kim et al. 
[77] reported that a “CD8+ Treg” cell subset in mice is capable of directly 
suppressing GC-Tfh cells expressing the non-canonical major histocompatibility 
complex class 1 molecule Qa-1, the homologue of human HLA-E. Analogous to 
classical CD8+ T cell cytotoxicity, CD8+ Tregs were dependent on IL-15 and 
perforin expression for their Tfh repressive function. Unlike conventional CD8+ 
cytolytic T cells, CD8+ Tregs were identified by high expression of CD44, 
ICOSL, and CXCR5, and were thus capable of homing to GC B cells. Hence, 
through their specific mode of cellular targeting and killing, highly dependent on 
TCR-based recognition of surface-bound Qa-1-peptide [78, 79], CD8+ Treg cells 
are distinct from immunosuppressive CD4+ Tfr cells. CD8+ Treg cells in HIV 
infected human patients have been implicated in dampening GC reactions via 
HLA-E-dependent targeting of virus permissive Tfh cells [80]. 
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Another non-MHCII-restricted GC T cell subset are the Natural killer Tfh or “NK-
Tfh” cells which develop from natural killer T (NKT) cells expressing semi-
invariant !" TCRs that respond to CD1d-presented glycolipid antigens derived 
from bacteria [81]. Activated NKT cells can co-opt the CD28- and BCL6-
dependent differentiation program of conventional Tfh cells to enter follicles and 
provide help to extrafollicular antibody responses [82, 83] and GCs [84-86]. Like 
their GC-Tfh counterpart, mouse NK-Tfh cells show high expression of CXCR5, 
PD-1, ICOS, CD40L and IL-21 [85, 86], and their formation requires stable 
B cell interactions via SAP signalling [87]. However, it remains unclear if human 
tonsil NK-Tfh cells, that display high expression of PD-1, CXCR5, BLTA and 
CD57 [85], have a role in immunity. 
 
1.2.3. Intracellular signalling pathways in Tfh cells 
Considerable advancement in our understanding of Tfh cell differentiation has 
been gained by examining genetically-manipulated mice and through ex vivo 
molecular dissection of Tfh cells, which has uncovered multiple signal 
transduction networks that converge to regulate Tfh cell responses.  
 
The cytokine mileau within a GC plays a key role in the generation of Tfh cells. 
Subsequent to being phosphorylated by activated IL-6 and IL-21 cytokine 
receptors at the surface of developing pre-Tfh cells, cytoplasmic STAT3 is 
imported into the nucleus, acting as a transcription factor to induce Bcl6 
expression and further Tfh cell differentiation [88, 89] (Figure 1.3.). STAT3 
competes against Tfh-inhibitory signals by type I interferon-directed STAT1 and 
IL-2-induced STAT5 for shared occupancy of various promoter and intergenic
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Figure 1.3.  Signal transduction pathways controlling Tfh cells  
Stimulation of T cell surface receptors activates multiple signal transduction 
cascades that can induce Tfh responses and gene expression (green) or trigger 
regulatory switches that antagonise Tfh cell differentiation (red). In general, TCR 
signals leading to the activation of the CARMA1/BCL10/MALT1 (CBM) 
signalosome are required for the activation of peripheral T cells, including Tfh 
cells. However, the role and requirement of all individual components of this 
TCR-CBM axis in Tfh development have not been formally tested. 
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binding sites on the Bcl6 locus [17, 90]. In addition to this STAT3-STAT1/STAT5 
competitive inhibition, STAT5 can also activate Prdm1, encoding for another 
trancriptional silencer of Bcl6 expression, BLIMP1 [91, 92]. 
 
Acting synergistically with cytokine receptor instruction, the inducible 
costrimulatory receptor ICOS has a vital role in Tfh differentiation. Upon ligation 
with B cell expressed ICOSL, ICOS receptor on activated T cells induces 
intracellular PI3K-AKT signals [93-95] that promote Tfh cell differentiation [96, 
97]. In turn, AKT phosphorylates the Bcl6 gene silencer FOXO1 (Figure 1.3.), 
prompting its nuclear exclusion and thus releasing trancriptional repression of 
Tfh polarising genes, allowing for the formation of terminally-differentiated GC-
Tfh cells [98]. Considering the potency of FOXO1 as a transcription factor for 
Foxp3 expression and in enforcing thymus-derived Treg and extrathymic Treg 
differentiation [99, 100], it is possible that FOXO1 deactivation in ICOS-
stimulated peripheral CD4+ T cells redirects their differentiation program from 
extrathymic Tregs to the Tfh lineage. Indeed, T cell-specific Foxo1 deletion 
results in spontaneous Tfh and GC expansion and severe systemic 
autoimmunity which may reflect both a lack of Tregs and exaggerated Tfh help 
to aberrantly-selected autoreactive GC clones [100]. 
 
Similar to ICOS, OX40 acts as a costimulatory receptor that facilitates CD28-
induced CXCR5 expression, which is important for Tfh cell differentiation [101]. 
Ox40 is normally highly expressed preferentially on primed CD4+ T cells 
amongst other leukocyte lineages. In virus-infected Ox40 knockout mice, a 
crippled Tfh cell response leads to severely diminished long-term titres of 
protective antiviral antibodies [102]. In human systemic lupus erythematosus 
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(SLE) patients, enhanced OX40 ligation on CD4+ T cells by an increased 
frequency of CD40L-expressing leukocytes is associated with autoimmune 
pathology possibly linked to unrestrained Tfh cell differentiation [103]. Although 
T cell OX40 can couple NF!B signals [104], blocking components of the 
canonical or non-canonical NF!B pathways, respectively controlled by IKK and 
NIK, does not impede on the TCR/CD28/OX40-dependent in vitro induction of 
BCL6 in primary human CD4+ T cells [103]. It is more likely that OX40 acts to 
augment TCR/CD28 crosstalk with PI3K signals to promote BCL6-dependent 
Tfh cell formation via AKT. This is consistent with AKT activity and OX40 
expression but reduced NF!B-associated TRAF6 induction in CD4+ T effector 
cells of human SLE patients [105]. 
 
1.2.4. Negative regulation of Tfh cells 
Tfh cell responses are kept under control by negative signals that act to contain 
excessive cellular growth and signalling to B cells so as to avoid unwarranted 
GC pathology. PD-1 is an inhibitory surface receptor typically on mouse and 
human CD4+ and CD8+ T cells [106]. Upon activation by its ligands PD-L1 and 
PD-L2, T cell expressed PD-1 recruits the cytoplasmic phosphatase SHP2 
which deactivates the TCR-associated tyrosine kinase ZAP70 and thus dampen 
TCR signals (Figure 1.3.). Importantly, Tfh cells express the highest levels of 
PD-1 in the periphery and in the GC, PD-1 receptor and its two ligands are all 
co-expressed on B cells. Surprisingly it has been documented that a lack of 
PD-1 signalling in mice allows for Tfh cell expansion and higher affinity Ig-
expressing B cells [107, 108]. Yet surprisingly in the same mice, PD-1 signalling 
is required for optimal GC reactions and GC-derived long-lived plasma cells and 
memory B cells. The major inconsistencies in these findings, that pit high Tfh 
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cell frequencies to low GC size and output, may stem from later observations 
that PD-1 deletion in mice results in an expansion of FOXP3+ Tfr cells and 
enhancement in their specialised role to suppress GCs and overall antibody 
production [109], possibly leading to a greater selection pressure for high affinity 
GC clones. This therefore highlights the importance of the molecular and 
functional diversity of different GC T cell subsets. 
 
Another emerging signalling pathway important for Tfh restriction is mediated by 
the RNA-binding protein ROQUIN (also called ROQUIN1), encoded by Rc3h1. 
Subject to proteolytic inhibition by the TCR-activated MALT1 paracaspase [110], 
ROQUIN acts to post-transcriptionally repress Tfh cells by binding T cell-
activating transcripts via its winged-helix ROQ domain [111-113] while recruiting 
proteins of the RNA decapping and deadenylation machinery [114-119]. These 
RNA-regulatory actions occur on translationally-inactive transcripts present in 
cytoplasmic messenger ribonucleoprotein (mRNP) foci, such as processing 
bodies (P-bodies) and stress granules. ROQUIN has emerged as a core 
component of these mRNP aggregates, which are ubiquitous in mammalian 
cells but transiently assemble in response to cytopathological stressors such as 
heat shock, viral infections, oxidative damage, ultraviolet irradiation and hypoxia 
[120], hyperosmotic pressure [121] and amino acid starvation [122]. Importantly, 
mRNP aggregates have also been reported to form in the cytoplasm of CD4+ 
T cells upon priming or subsequent TCR re-stimulation [123].  
 
Some mRNA targets of ROQUIN include the Tfh-polarising Icos [115], Il6 mRNA 
[110] (Figure 1.3.) as well as Ox40 [119] transcripts. ROQUIN was shown to 
specifically bind a conserved sequence motif, called constitutive decay element 
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(CDE), within the 3’ untranslated region of these transcripts [116]. In sanroque 
mice, an Rc3h1 missense point mutation, encoding for a Met199Arg substitution 
(ROQUINM199R) translates to a small conformational shift in the RNA-binding 
ROQ domain [124] and a loss of function in post-transcriptional repression. This 
leads to excessive Tfh growth and systemic autoimmunity. T cell Ifng mRNA 
accumulation was shown to be essential for the Tfh hypercellularity and the 
autoimmune pathology of sanroque mice [125], although the transcript has not 
been described to bind to ROQUIN directly, nor harbour a target CDE [116].  
 
Complete ablation of ROQUIN results in unexplained perinatal lethality in 
C57BL/6 mice and selective deletion of ROQUIN neither in T cells or all 
haemopoietic cells leads to Tfh cell accumulation or autoimmunity [126]. These 
phenotypic discrepancies may be explained by ROQUINM199R mutant protein 
acting as a “niche-filling” variant that has lost its RNA-regulating activity [117]. 
ROQUINM199R can still localize to mRNA-regulating cytoplasmic mRNP foci but 
partially prevents compensatory activity of the closely related family member 
ROQUIN2 (also called MNAB), thus indicative of an epistatic genetic 
dominance. The ability of ROQUIN to shuttle to cytoplasmic mRNP granules 
appears to be abrogated by complete deletion of its ROQ domain, although it 
remains unclear why ROQ defective ROQUINM199R, found in sanroque mutant 
T cells, retains normal mRNP granule migratory competence [114]. 
 
1.3. The immunological role of ROQUIN 
ROQUIN was discovered in 2005 [45] through the identification of the sanroque 
mouse mutant presenting with a striking autoimmune phenotype. These mutant 
mice exhibit spontaneous T cell activation, unrestrained Tfh and GC B cell 
 18 
accumulation, hypergammaglobulinemmia, glomerulonephritis, 
lymphadenopathy and circulating antibodies against nuclear antigens and 
dsDNA, which are hallmarks of human SLE. Genetic deletion of CD28 or SAP 
signalling in sanroque mice was sufficient and necessary for Tfh-specific 
ablation and amelioration of the lupus-like phenotype [42]. In addition, ICOS 
haploinsufficiency within sanroque also resulted in near normalised Tfh cell 
numbers and rescue of lymph node size [118] but complete ICOS deletion did 
not abrogate the production autoantibodies, which in the absence of ICOS are 
likely derived from self-reactive ICOS-independent extrafollicular B cells [127-
129]. Similarly, deletion of IL-21 did not alter Tfh cellularity nor the autoimmune 
pathology in sanroque mutants [42], probably due to increased stability of Il6 
mRNA, another ROQUIN target [110], which has overlapping functions with 
IL-21 in promoting both Tfh cell differentiation and plama cell formation [130]. 
 
Since these initial observations, ROQUIN has been described as a potent Tfh 
cell repressor, acting through its synergistic ROQ and C3H1 domains in mRNP 
granules to destabilise Tfh-activating RNA molecules for the prevention of 
hyperactive T-dependent humoral responses leading autoantibody production. 
However, ROQUIN does not only harbour ROQ and C3H1 domains. It is 
possible that ROQUIN may also be influencing Tfh cells through its other highly 
conserved protein regions, for instance, its amino terminal RING domain which 
currently has no known role in mammalian cellular physiology but is predicted to 
facilitate protein ubiquitination. 
 
The Caenorhabditis elegans ROQUIN orthologue, RLE-1, acts through its RING 
domain to promote ubiquitination of DAF-16, a pro-longevity forkhead box O 
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(FOXO) transcription factor homolog [131]. Also, the ROQUIN mammalian 
paralogue, ROQUIN2, was found to act as a RING-type E3 ligase for ASK1 
ubiquitination in response to oxidative stress [132]. Given the evolutionarily 
conserved and ubiquitous role of RING domains in driving protein substrate 
ubiquitination [133], especially in T cell autoimmunity, malignancies and 
inflammation [134], dissecting how the ROQUIN RING domain may be 
functioning in Tfh cell responses is likely to illuminate the pathogenesis of these 
poorly understood diseases. 
 
1.4. Research objectives 
How the ROQUIN signalling pathway is able to limit Tfh cell gene expression 
and regulate T-dependent humoral immune responses linked to systemic 
autoimmunity remains incompletely understood. Although this thesis is 
generally concerned with understanding the molecular basis for controlling Tfh 
cells, there is a specific focus on dissecting the biomolecular and physiological 
role of ROQUIN in mammalian T cell immunity, and establishing whether it 
functions as a RING-type E3 ubiquitin ligase. There are three principal research 
aims for the present study: 
(i) Characterise the CD4+ T cell immunological relevance of the ROQUIN 
RING domain in vivo. Phenotypic analysis can be performed on two 
novel mouse strains lacking Rc3h1 exon 2, encoding for the ROQUIN 
RING domain; ringless mice are germline-deleted for the ROQUIN RING 
domain and Tringless mice harbour an identical exonic deletion restricted 
only to T cells by the conditional Cre recombinase system. 
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(ii) Examine the potential E3 ubiquitin ligase activity of ROQUIN by 
molecular interrogation of its RING domain and the identification of a 
cellular target(s) dependent on ROQUIN RING activity. 
(iii) Reconcile the immune phenotype of sanroque and ROQUIN RING 
deleted mice by genetic complementation of the different Rc3h1 alleles 
and utilize existing knowledge of how ROQUIN functions to limit T cell 
RNA targets to clarify the role of ROQUIN in T-dependent immune 
responses. 
 
1.5. Hypotheses 
(i) The ROQUIN RING domain may be a contributing factor to maintaining 
T cell tolerance, which is otherwise deregulated in sanroque mice 
expressing mutant ROQUIN. It is possible that ROQUIN RING deficiency 
results in the autoactivation of T cells, augmenting effector 
subpopulations that can contribute to systemic autoimmune disease. 
(ii) Based on homologous studies in nematode worms, we postulate that the 
lymphoid-specific members of the FOXO family of nuclear factors, 
namely FOXO1 and FOXO3a are likely substrates of mammalian 
ROQUIN RING-mediated E3 ligase activity in T cells. 
(iii) Given the extensive pathology observed in sanroque mice, the ROQUIN 
RING domain may be acting independently but in harmony with, or even 
amplifying the loss of activity of, adjacent RNA regulatory domains of 
ROQUIN. Together the multiple ROQUIN domains may be important to 
jointly shape Tfh cell responses. 
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chapter two 
2. Materials and methods 
2.1. Mouse experiments 
ringless and Tringless mice were generated by Ozgene. These mice containing 
a floxed Rc3h1 exon 2 were crossed to Rosa26:Cre or Lck:Cre knock-in mice, 
provided by Ozgene to induce Rc3h1 exon 2 deletion in Cre expressing cells. 
The genetic strategy behind the design of the ringless and Tringless mice is 
detailed in section 3.2.1. ENU-derived sanroque and chino mutants were 
previously characterised by Vinuesa et al. [45] and Daley et al. [135], 
respectively. Vav:Bcl2 mice were previously reported by Egle et al. [136]. 
 
Mouse experiments were approved by the Animal Experimentation Ethics 
Committee of the Australian National University. Mice were maintained in-house 
under a specific germ-free environment. When possible, mouse sex was 
matched in experiments. Where indicated, 8 to 12 wo mice were immunised i.p. 
with 2 x 109 SRBC or with 2 x 105 PFU of LCMV Armstrong to generate a T cell-
dependent GC response. For pharmacological inhibition of mTOR in mice, 5 
mg/kg Rapamycin (dissolved in 5% DMSO in PBS) or a vehicle control solution 
(5% DMSO in PBS) was injected i.p. in alternating sides 5 times per week for 4 
weeks. 
 
2.2. Bone marrow chimeras 
To generate mixed bone marrow chimeric mice, recipient Rag1-/- mice were 
sub-lethally irradiated with 500 rad and reconstituted via i.v. injection with 2x106 
donor bone marrow-derived hematopoietic stem cells. Recipient (transplanted) 
mice were then recovered for 8-12 weeks prior to immunisation and/or analysis. 
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2.3. Polymerase chain reaction (PCR) 
PCRs were carried out on cDNA template prepared from either FACS sorted 
CD4+ T cells from mouse spleens or primary MEFs. cDNA preparation involved 
freezing cells in Trizol (ThermoFisher Scientific) for the separation of total RNA 
according to the manufacturer’s instructions. RNA extracts were then used to 
synthesise first-strand cDNA with Moloney Murine Leukemia Virus Reverse 
Transcriptase (M-MLV RT) (Invitrogen) following the protocol prescribed by the 
enzyme manufacturer. 
 
Typical PCR reactions were prepared with a total volume of 20 µL in thin-walled 
0.2 mL PCR tubes and performed using Taq DNA polymerase (Scientifix). A 
single reaction mix was composed of 10 ng of first-strand cDNA, 1x DNA 
polymerase buffer, 2 µL dNTP mix (2.5 mM), 2 µL of the forward primer (5 µM), 
2 µL of the reverse primer (5 µM), and 1 U of Taq polymerase. The reaction mix 
was then made to volume with sterile water before thermal cycling for cDNA 
amplification. PCR cycling conditions consisted of a single run of Cycle 1 (95°C 
for 2 min), 30 repetitions of Cycle 2 (95°C for 30 s; then [lowest Tm of the 
primer pair] – 5°C for 30 s; then 72°C for [1 min of extension time per kbp of 
predicted amplicon]), and a final run of Cycle 3 (72°C for 3 min).  
 
Custom oligonucleotides were manually designed, purchased from Geneworks 
and used as primers for PCR amplification of C57BL/6 mouse cDNA regions. 
Four primers were used to target Rc3h1 from first-strand cDNA: 
MmRc3h1-Exon1F: GGGACAGAGTCAGAGTCGATG 
MmRc3h1-Exon3R: TGGCTTCCTCATAATGCTTTG 
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ROQDomF: GGCTCTAGAATTCCGCAATGGTGACTCTGGTTCATTGCCAG 
ROQDomRev: GCCTGCGGCCGCGTAGCTCCTGAACACTCTGTGC 
Underlined regions represent sequences annealing to target cDNA template. 
“MmRc3h1-Exon1F” and “MmRc3h1-Exon3R” primers were developed to 
amplify the span between Rc3h1 exons 1 to 3. Primers “ROQDomF” and 
“ROQDomRev” were kindly donated by Dr. V. Athanasopoulos and bind within 
Rc3h1 exons 4 and 7, respectively. 
 
2.4. Cell isolation, stimulation, and culturing 
Cell suspensions were prepared from spleens of unimmunised or immunised 
mice. Cell suspensions were prepared in RPMI 1640 medium (Invitrogen) 
supplemented with 2 mM L-glutamine (Invitrogen), 100 U penicillin-streptomycin 
(Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 100 mM HEPES 
(Sigma-Aldrich), 0.0055 mM 2-mercaptoethanol, and 10% Fetal calf serum 
(FCS) by sieving and gentle pipetting through Falcon 70µm nylon mesh filters 
(BD Biosciences). Where indicated in vitro stimulation of T cells was performed 
using anti-CD3 and anti-CD28 dual coated Dynabeads (Invitrogen) or for 
cytokine accumulation, 50 ng/mL phorbol-12-myristate-13-acetate (PMA) 
(Sigma-Aldrich), and 500 ng/mL ionomycin (Sigma-Aldrich) was used with 
GolgiStop (BD Biosciences) diluted at 1:1000. 
 
For the in vitro polarisation of CD4+ T cell effector cells, FACS sorted naïve 
CD4+CD44lowCD25! T cells were stimulated with anti-CD3 and anti-CD28 dual 
coated Dynabeads (Invitrogen), as indicated above. 20 ng/mL IL-2 (R&D 
Systems), 100 ng/mL IL-4 (Miltenyi Biotec), 100 ng/mL IL-6 (Peprotech), 20 
ng/mL IL-12 (Miltenyi Biotec), 1 ng/mL TGF! (R&D Systems), along with 
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1mg/mL of Biolegend antibodies anti-IL-4, anti-IFN! and/or anti-IL-12 were used 
for (IL-2) Th0 conditions, (IL-2, IL-12, and anti-IL-4) Th1, (IL-2, IL-4, anti-IFN!, 
and anti-IL-12) Th2, (IL-2, IL-6, TGF!, anti-IL-4, and anti-IFN!) Th17, and (IL-2 
and TGF!) iTreg cultures. 
 
2.5. Flow cytometry 
To stain surface markers, cell suspensions were washed and stained in ice-cold 
FACS buffer maintained in the dark at 4oC throughout. eBioscience FOXP3 
Staining Buffer Set was used for flow cytometric detection of intracellular 
proteins. Cell suspensions were washed thoroughly with FACS buffer between 
each layer of cell surface or intracellular stain.  
 
Staining panels consisted of commercial antibodies (clones indicated in 
parentheses) against CD4 (GK1.5), CD44 (IM7), ICOS (7E.17G9), LY5A (A20), 
and PD-1 (29F.1A12) were obtained from BioLegend; antibodies against B220 
(30-F11), BCL6 (K112-91), CD25 (3C7), CD62L (MEL-14), CXCR5 (2G8), KI67 
(B56) and T/B cell activation antigen (GL7) were obtained from BD Biosciences; 
antibodies against FAS (15A7), FOXP3 (FJK-16S), and streptavidin conjugates 
were obtained from eBioscience. 7AAD (BD Pharmingen) and Live/Dead Aqua 
(Life Technologies/Invitrogen) were also used to stain samples and exclude 
dead cells during analysis. Cell suspensions, were washed twice prior to flow 
cytometric analysis. FACS data was acquired by a LSRII or Fortessa Flow 
Cytometer (BD Biosciences) using FACSDiva software. FlowJo software was 
used for post-acquisition data analysis. 
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2.6. Cell lines 
HEK293T and EL4 cells were obtained from the ATCC and perpetuated in-
house. Primary mouse embryonic fibroblast (MEF) cells were harvested from 
e14 fetuses of rin/+ or san/+ pregnant females after being paired with rin/+ or 
san/+ males, respectively, as part of a timed mating. 
 
Transfection of cells with expression plasmids was performed using 
Lipofectamine 2000 (Invitrogen) transfection reagent in accordance to the 
manufacturer’s protocol. 
 
2.7. Plasmid constructs 
N-terminal V5-tagged full-length Mus musculus ROQUIN and truncated 
ROQUIN133-1130 constructs as well as C-terminal GFP-fused ROQUIN and 
ROQUINC14A constructs were also generated by Dr. V. Athanasopoulos. Homo 
sapiens FOXO1 (Cat. 9022) and FOXO3a (Cat. 10708) expression plasmids 
were sourced from Addgene. GFP tagged constructs of AMPK !1, !2, !1, !2, 
!1, !2 and !3 subunits were obtained from Origene. ROQUIN1-484 and 
ROQUIN145-484 GST-fusion constructs on a pGEX-6P-1 background were 
generated by Dr. V. Athanasopoulos and Dr. J. Babon, respectively. 
 
2.8. Fluorescence microscopy 
Untransfected or transfected MEFs and HEK293T cells were seeded on 
coverslips and prepared for fluorescence microscopy by fixing in 3.7% 
formaldehyde for 15 min at room temperature. Cells were permeabilised with 
1% Triton X-100 for 5 min, washed in PBS buffer (pH 7.4) and blocked in 5% 
BSA/0.1% Tween 20 in PBS for 1h at room temperature before staining with 
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primary antibodies for 1h at room temperature, or overnight at 4oC. Cells were 
again washed three times in PBS/0.05% Tween 20 and stained with 
fluorescently tagged secondary antibodies for 1h at room temperature. Finally, 
cells were again washed three times in PBS/0.05% Tween 20 and either 
counter-stained with 4’,6-diamidino-2-phenylindole (DAPI) for 5 min before 
mounting in Vectashield or mounted directly in Vectorshield  containing DAPI 
(Vector Laboratories). Preparation of slides for the detection of phospho-specific 
antigens/proteins used blocking and washing buffers containing TBS in place of 
PBS. Images were collected using an Olympus IX71 microscope with DP 
Controller software (Olympus).  
 
2.9. Immunoprecipitation and immunoblotting 
Whole-cell lysates were prepared using TNE lysis buffer (1% NP40, 150 mM 
NaCl, 20 mM Tris-base, 1 mM EDTA and Roche cOmplete EDTA-free protease 
inhibitory cocktail tablets all dissolved in ddH20). PhosSTOP (Roche) was 
added to the TNE mix for the detection of phospho-residues. Alternatively, TNE 
buffer was supplemented with ubiquitin aldehyde (Calbiochem/Merck Millipore) 
for the detection of ubiquitinated proteins. To immunoprecipitate (IP) proteins, 
antibody was added to pre-cleared lysates and mixed with Protein G Sepharose 
4 Fast Flow (GE Healthcare) for 12 h. Samples were then thoroughly washed in 
cold TNE lysis buffer three to five times with a final aspiration step leaving 
minimal but visible liquid buffer with IP pellets. All lysate and IP samples were 
boiled in sample buffer (3% SDS powder, 20 mM Tris-base at pH 7.5, 10% 
Glycerol, 0.002% Bromophenol Blue, and 5% 2-Mercaptoethanol, made to 
volume with ddH20) for 5 min before cooling at room temperature and loaded 
onto polyacrylamide gels. 
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The common Laemmli method was followed for the preparation of buffers, 
stacking and resolving polyacrylamide gels for sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), and the transfer of protein 
samples onto nitrocellulose membranes. Typically, an 8% acrylamide resolving 
gel (2 mL of 1M Tris-base at pH 8.8, 2.13 mL of 30% Acrylamide, 3.75 mL 
ddH2O, 25 µL of 20% SDS, 80 µL of fresh 10% ammonium persulfate, and 8 µL 
TEMED) below a 4% acrylamide stacking gel (2 mL of 1M Tris-base at pH 6.8, 
1.07 mL of 30% Acrylamide, 4.83 mL ddH2O, 25 µL of 20% SDS, 80 µL of fresh 
10% ammonium persulfate, and 8 µL TEMED) was used. For improved 
discrimination of similarly sized high molecular weight proteins, the acrylamide 
gradient of 4–20% Mini-PROTEAN TGX precast gels (Bio-Rad) was used. 
Loaded gels were run on the Mini-PROTEAN Tetra Cell electrophoresis 
chamber (Bio-Rad) in running buffer containing 25 mM Tris-base, 0.2 M glycine, 
and 3.5 mM SDS, all dissolved in ddH2O. SDS-PAGE separated proteins were 
then transferred from gels onto nitrocellulose membrane using the Mini Trans-
Blot Cell electrophoresis chamber (Bio-Rad) in 4oC transfer buffer containing 25 
mM Tris-base and 0.2 M glycine dissolved in ddH2O, with methanol at a final 
concentration of 20%. Membranes were immediately blocked overnight at 4oC 
with mild agitation in 5% BSA Tris-buffered saline (pH 8) containing 0.05% 
Tween-20.  Blocked membranes were then probed with primary antibodies and 
detected with horseradish peroxidase-conjugated anti-rabbit or anti-mouse 
secondary antibodies. Immunoblots were developed using Western Lightning 
PLUS Enhanced Chemiluminescence substrate (PerkinElmer) and visualised 
on an ImageQuant LAS 4000 imaging system (GE Healthcare). 
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2.10. Molecular reagents 
The following antibodies were used in Western blots, immunoprecipitation 
assays and fluorescence microscopy: rabbit anti-phospho-ACC Ser79 (Cat. 
3661, Cell Signaling), rabbit phospho-RAPTOR Ser792 (Cat. 2083, Cell 
Signaling), rabbit anti-!-ACTIN (13E5, Cell Signaling), anti-AMPK! Ig (rabbit-
derived Cat. ab32047, Abcam, or goat-derived clone C20, Santa Cruz), goat 
anti-eIF3 (N-20, Santa Cruz), anti-GFP Ig (mouse-derived 7.1 and 13.1, Roche, 
or rabbit-derived Cat. ab290, Abcam), anti-HA Ig (mouse HA-7, Sigma-Aldrich, 
or rabbit-derived H6908, Sigma-Aldrich), rabbit anti-RAPTOR (24C12, Cell 
Signaling), rabbit anti-ROQUIN (Cat. A300-514A, Bethyl Laboratories, or Cat. 
NB100-655, Novus Biologicals), mouse anti-UBIQUITIN (P4D1, Cell Signaling), 
anti-V5 Ig (mouse-derived V5-10, Sigma-Aldrich, or rabbit-derived Cat. V8137, 
Sigma- Aldrich), mouse anti-rabbit IgG light chain (211-032-171, Jackson 
ImmunoResearch), and goat anti-mouse IgG light chain (155-035-174, Jackson 
ImmunoResearch). AICAR (Calbiochem) and Compound C (Calbiochem) were 
used according to the manufacturer’s recommendations at indicated 
concentrations. 
 
2.11. Proximity ligation assays 
MEFs were seeded on sterile coverslips and cultured overnight in complete 
DMEM media supplemented with 10% FCS. To induce cellular stress, 1 mM 
arsenite was added to MEF covered coverslips for 1 h with 5% CO2 incubation 
at 37oC. Stains with primary antibodies were carried out using optimised 
conditions overnight at 4oC in a humid chamber. The primary antibodies were 
goat anit-AMPK!1 (clone C20, Santa Cruz); with either rabbit anti-ROQUIN 
(Cat. NB100-655, Novus Biologicals) or rabbit anti-GFP (Cat. ab6556, Abcam, 
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UK). Application and ligation of PLA probes were conducted using the DuoLink 
In Situ Red PLA kit (Olink Bioscience) according to the manufacturer’s protocol. 
Images were taken on a Leica SP5 confocal microscope with a pin-hole of 67.9 
mm and an APO CS 1.25 UV x40 oil objective. Higher magnification images 
were taken on a Leica SP5 confocal microscope with a pin-hole of 95.5 mm and 
an HCxPL APO lambda blue x63/1.4 oil objective. Single ligation events in PLAs 
were assessed by ImageJ 1.46r software (NIH). 
 
2.12. AMPK kinase assay in CD4+ T cells 
CD4+ T cells were isolated from floxed wild-type or Tringless mice by MACS 
Microbead separation (Miltenyi Biotec). AMPK activity against SAMS peptide 
was measured from AMPK complexes immunoprecipitated from cell lysates 
using anti-AMPK! antibody (Abcam) as previously described [137]. 
Immunoblots for Acetyl CoA Carboxylase (ACC) Ser79 phosphorylation levels 
were also used to measure AMPK allosteric activity. 
 
2.13. In vitro autoubiquitination assays 
Mouse UBCH5A (E2) was expressed as a GST-fusion protein and purified 
using standard protocols. ROQUIN1-484 and ROQUIN145-484 were also expressed 
as GST-fusion proteins using standard procedures except that 0.1 mM Zn-
acetate was added to the growth media and all purification buffers. Human E1 
(His6 tagged) was purchased from Biomol International. Bovine UBIQUITIN was 
purchased from Sigma-Aldrich. Ubiquitination assays were performed in 20 ml 
in 20 mM Tris-HCl, 50 mM NaCl, 2 mM MgCl2, 1 mM ATP, 0.1 mM DTT at 25oC. 
Reactions were stopped by the addition of 2x SDS PAGE loading buffer and 
heating at 95oC for 5 min and analysed by SDS-PAGE and Coomassie Blue 
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staining. Typically reactions contained 0.1 mM E1, 10 mM E2, 50 mM 
UBIQUITIN, and 0.5 mg/mL ROQUIN peptide. 
 
2.14. Autoantibody enzyme-linked immunosorbent assay (ELISA) 
Serum obtained by orbital eye bleed from 8-12 week-old mice was diluted in 
PBS 1:40 for antinuclear antibody (ANA) detection. Serum ANA titres were 
measured with mouse ANAs Total Ig ELISA kit (Alpha Diagnostic) according to 
the manufacturer’s instructions. In brief, 100 µL serum and standards were 
incubated in 96-well plates pre-coated with purified extractable nuclear antigens 
for 60 min at room temperature. Plates were then thoroughly washed and 
100 µL of goat anti-mouse Ig coupled with horseradish peroxidase was added 
and incubated for 30 min. This was followed by further washes before the 
addition of 100 µL 3,3!,5,5!-tetramethylbenzidine (TMB) substrate with 
incubation for 15 min in the dark. 100 µL stop solution was used to terminate 
colourimetric development of ELISA reactions. Plates were then read at 405 nm 
with an Infinite 200 Pro microplate reader (Tecan). ANA concentrations were 
calculated relative to mouse ANA standards. 
 
2.15. Histopathology 
Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin. 8 
µm sections were stained with Periodic acid–Schiff (PAS) and Cresyl Violet-
Luxol fast blue (CV-LFB) for analysis under a light microscope. 
 
2.16. Statistical analyses 
Statistics were calculated using Prism 5.0a software (GraphPad). As indicated 
in figure legends, an unpaired Student’s t-test was applied for comparisons 
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between two sample groups, with pairing used for the analysis of congenically 
marked cells in the same chimeric mouse. A one-way ANOVA test with 
Bonferroni correction was used for analysis of multiple sample groups. Given 
their intrinsic asymmetric distribution, ratio values were log transformed prior to 
statistical analysis. A Chi-square test was conducted for assessment of 
germline transmission of the rin allele.  
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chapter three 
3. Development of a novel mouse strain to  
study ROQUIN RING-deficient T cells 
 
3.1. Preamble 
3.1.1. RING-type E3 ligases in T cell immunity 
In the adaptive immune system, RING-mediated ubiquitination of intracellular 
proteins is tightly associated with the maintenance of T cell immunological 
tolerance. CBL-B is an example of an E3 RING ubiquitin ligase that represses 
T cell effector molecules PLC! [138] and PI3K [139, 140] via ubiquitination 
downstream of TCR signalling and CD28 costimulation, respectively. CBL-B 
ubiquitination of PLC! leads to its reduced phosphorylation and delayed 
degradation. In contrast, CBL-B ubiquitination of the p85 regulatory subunit of 
PI3K in Jurkat cells does not result in p85 degradation but interrupts PI3K 
associating with the cytoplasmic regions of the CD28 receptor. Consequently, 
TCR-stimulated T cells from Cblb knockout mice show uncontrolled proliferation 
and hyperproduction of IL-2 independent of costimulation leading to the 
development of spontaneous systemic autoimmunity in vivo [141] and 
increased experimental autoimmune encephalomyelitis (EAE) disease 
susceptibility [142].  
 
A similar phenotype is observed in mice deficient in another RING-type E3 
ligase GRAIL. In Grail-/- mice, a hyperproliferative T cell response and 
exaggerated cytokine production in the absence of costimulation leads to 
spontaneous autoimmunity with circulating autoantibodies against dsDNA and 
exacerbated Th17-driven EAE [143]. Unlike CBL-B however, GRAIL is a 
transmembrane enzyme that commonly targets the cytoplasmic regions of 
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similar membrane-bound proteins like the TCR complex CD3 !-chain [143] and 
CD40L [144], promoting their ubiquitin-mediated degradation. In the regulation 
of Th2-mediated inflammatory responses, GRAIL also down-modulates its own 
transcriptional activator STAT6 for proteolytic ubiquitination as a form of 
negative feedback [145]. Not all GRAIL substrates are ubiquitin tagged for 
proteosomal degradation. GRAIL can facilitate Lys63-linked polyubiquitination of 
RHODGI, improving its protein stability and leading to the inhibition of RHO 
GTPase signalling, which is otherwise required for actin reorganization and IL-2 
production in T cell effector responses [146]. 
 
Early studies of another E3 ligase TRAF6 highlighted its essential role in NF!B 
activation by transducing CD40, IL-1R and TLR4 signals in a vast range of 
immune cells, including B cells, thymocytes, dendritic cells and macrophages 
[147-151]. It was similarly described in mature T cells, that the function of 
TRAF6 was to mediate TCR stimuli for the activation of NF!B signalling [152, 
153]. Specifically, through its amino terminal RING domain, TRAF6 Lys63-
polyubiquitinates MALT1 to recruit and activate the IKK complex, which acts to 
liberate the NF!B heterodimeric nuclear factor responsible for effecting T cell 
responses. However, TRAF6 deficient T cells in vivo paradoxically show 
hyperactive PI3K signalling leading to Treg resistance and augmented Th2 
responses that drive systemic autoinflammatory and autoimmune disease [154, 
155]. Subsequent studies clarified the role of TRAF6 RING-mediated activation 
of NF!B in the formation and maintenance of Tregs and their stable FOXP3 
expression, which is essential for curtailing unrestrained Th2 responses that 
may drive excessive type 2 inflammation [156, 157]. 
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3.1.2. A putative role for the ROQUIN RING domain in T cell immunity 
ROQUIN remains a putative E3 ubiquitin ligase in T cells since, to date, no cell 
signalling potential has been attributed to its E3-associated RING domain and 
no protein substrate has been identified as a target of ROQUIN-mediated 
ubiquitination in mammals. This is despite the highly conserved amino terminal 
ROQUIN structure containing a distal RING domain (Figure 3.1.). Considering 
the tolerogenic actions of many known T cell RING-type E3 enzymes, it is 
plausible that ROQUIN ubiquitin ligase activity promotes immune homeostasis 
by curtailing T cell hyperactivity. However, an evolutionary link with its C. 
elegans ancestor, RLE-1, acting through its RING domain to drive DAF-16 
polyubiquitination and degradation [131], exposes a possible 
immunostimulatory function for ROQUIN. It is possible that the ROQUIN RING 
domain promotes destabilisation of the DAF-16 orthologue, FOXO3a, the most 
highly conserved member of the FOXO nuclear factor family and reported to 
repress CD4+ T cell autoactivation, hyperproliferation and autoreactivty in an 
early study of 129S1 mice [158].  
 
In light of the above studies, genetically altered mice lacking the ROQUIN RING 
region were developed to decifer the predicted ROQUIN E3 ligase role in 
mammalian physiology. This chapter details the strategy for generating 
ROQUIN RING deficient mice. Also described is the phenotype of the ROQUIN 
RING deficient mice with a particular focus on CD4+ T cell immunological 
perturbations to provide first insight into ROQUIN RING putative signalling in T-
dependent humoral responses in vivo. 
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Figure 3.1.  The conserved ROQUIN amino terminus 
Schematic representation of the ROQUIN protein secondary structure in various 
eukaryotic species. An amino terminal RING domain (red) spanning from Cys
14
 
to Asp
53
 in mouse ROQUIN is found highly conserved in all ROQUIN homologs 
of the ROQ family of RNA-binding proteins. Other functional protein domains 
are also annotated (grey). 
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3.2. Results 
3.2.1. A genetic strategy for ROQUIN RING domain ablation in mice 
To examine the function of the ROQUIN RING domain in vivo we sourced from 
Ozgene two strains of C57BL/6 mice carrying either a germline deletion or T cell 
conditional deletion of exon 2 in the Rc3h1 gene, which encodes the translation 
START codon and RING finger domain of the ROQUIN protein. ROQUIN RING 
deleted mice were generated by insertion of loxP sites that flanked or “floxed” 
Rc3h1 exon 2, encoding the START codon and RING motif (Figure. 3.2.a). 
Introduction of loxP sites into Rc3h1 was achieved by homologous 
recombination in C57BL/6 mouse embryonic stem (ES) cells that were 
implanted into foster mothers. Heterozygote progeny were screened for 
germline transmission before crossing to Rosa26:Flp1 mice to remove the neo 
cassette. Mice harbouring the floxed Rc3h1 allele were then backcrossed 4-5 
generations to C57BL/6. Floxed Rc3h1 heterozygotes (Rc3h1lox/+) were then 
crossed to Rosa26:Cre knock-in mice for one generation. Removal of Cre 
expression was then achieved by a C57BL/6 backcross yielding a germline 
deletion of Rc3h1 exon 2. This strain was named ringless (rin allele). A 
conditional ROQUIN RING deficient strain (called Tringless) was also generated 
by crossing Rc3h1lox/lox mice to Lck:Cre breeders to remove Rc3h1 exon 2 
specifically in T lymphocytes (Trin allele). 
 
Upon Cre-mediated excision of Rc3h1 exon 2, rescue of an alternative in-frame 
Kozak translation initiation site at Met133 (Figure 3.2.b) is expected to produce 
an E3 ligase defective ROQUIN mutant containing residues 133-1130 (Figure 
3.2.c). Rosa26:Cre and Lck:Cre mice were maintained on a C57BL/6 
background with one copy of the Cre transgene.  
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Figure 3.2.  Generating mice with a ROQUIN RING deletion 
(a) Generation of ringless or Tringless mice with a deletion of Rc3h1 exon 2 
when crossed to Rosa:Cre or Lck:Cre transgenic strains, respectively. White 
boxes, non-coding exons; black boxes, protein encoding exons; NeoR, 
Neomycin resistance cassette. (b) Alignment of the mammalian Kozak 
sequence and alternative ROQUIN translational start site at Met
133 
in ringless. 
Solid lines, identical; dotted lines, similar. (c) ROQUIN protein map lacking the 
14.5 kDa RING finger with translational rescue at Met
133
. 
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To confirm Rc3h1 transcription occurred in ROQUIN RING deficient mice albeit 
with the exclusion of exon 2 encoded sequences, PCR was conducted using an 
exon 1 forward primer and a reverse primer in exon 4 (schematically depicted in 
Figure 3.2.a) on cDNA from ringless mouse embryonic fibroblasts (MEFs) and 
from sorted splenic CD4+ T cells from Tringless mice. By gel electrophoresis 
separation of PCR amplicons, it was determined that 380 bp of cDNA was 
lacking in ringless (Figure 3.3.a) and Tringless (Figure 3.3.b) samples 
compared to wild-type littermate controls. The size of the deleted sequence was 
consistent with that of exon 2. As a parallel internal control, PCR amplification of 
downstream cDNA sequences covering the ROQ domain remained intact and 
unaffected by Cre-mediated excision. Subsequent Sanger sequencing on cDNA 
also showed skipping of exon 2 resulted in normative splicing of exon 1 to exon 
3 in both ringless MEF (Figure 3.3.c) and Tringless (Figure 3.3.d) cells. From 
this, it was concluded that in both ringless and Tringless samples, Rc3h1 exon 2 
was accurately removed. Because this region encoded the ROQUIN native 
translation start site and RING domain, these sequences were therefore 
verifiably deleted. 
 
To confirm if Rc3h1 exon 2 targeted deletion resulted in complete ablation of 
ROQUIN protein synthesis on account of loss of the native translation start site, 
protein blot analyses of cell lysates were performed using specific antibody 
against the ROQUIN Gly500 to Pro550 region. Anti-ROQUIN protein blots revealed 
that approximately 14.7 kDa of protein was lacking in Rc3h1 exon 2-deleted 
samples as predicted (Figure 3.3.e,f), compared wild-type with full length 125 
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Figure 3.3.  Validation of Rc3h1 exon 2 Cre-driven deletion 
(a-d) Deletion of Rc3h1 exon 2 detected in primary MEFs (left) and CD4
+
 T cells 
(right) by Polymerase chain reaction (PCR; a,b) and sequencing (c,d) from 
cDNA. (e) Western blots of ROQUIN protein on primary MEF lysates. (f) 
Immunoprecipitation assay for the detection of ROQUIN protein from mouse 
thymocytes. IB, immunoblot; IP, immunoprecipitation. Immunoblots are 
representative of at least three independent experiments 
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kDa ROQUIN. This suggested rescue of ROQUIN protein synthesis by an 
alternative translation initiation site at the next Met133 codon. Therefore, in 
Rc3h1 exon 2-deficient cells, the resulting ROQUIN133-1130 protein variant 
specifically lacks the RING domain but contains sequences downstream of 
Met133 including all other functional ROQUIN domains. Whether Met133 only 
represents an artificially-induced translation start site in ringless and Tringless 
mice or also occurs naturally in ROQUIN isoforms remains unclear.  
 
3.2.2. Germline ROQUIN RING deficiency causes perinatal lethality 
Heterozygous ringless males and females appeared physically healthy, 
indistinguishable from wild-type littermates and were used to maintain breeding 
of the ringless strain. A focused examination of the heterozygous ringless 
mouse phentype was performed by J. Fitch (2009, Honours Thesis). Mice 
homozygous for the rin allele were perinatally lethal and thus precluding T cell 
studies in intact mice. Mendelian ratios of rin homozygous e14 and e19 fetuses 
were observed but no 10d-old ringless neonates were detected, indicative of a 
fully penetrant early survival defect associated with ROQUIN RING deficiency 
(Figure 3.4.a). These mice exhibited intrauterine growth retardation and 
incomplete neural tube closure at e14 (Figure 3.4.b) and e19 (Figure 3.4.c). 
Developmental neural tube defects were verified by histology using luxol fast 
blue-cresyl violet (LFB-CV) stained transverse sections of the e19 fetal lumbar 
posterior (Figure 3.4.d). 
 
Because Bertossi et al. [126] reported that mice with a complete ROQUIN 
deletion die postnatally within 6 h due to improper lung function, we performed 
histological examination of the thoracic diaphragm of e19 ROQUIN RING  
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Figure 3.4.  An early developmental phenotype in ringless mice 
(a) In utero and litter count from ringless heterozygous breeding 
(n = 100 per time point). Statistics were calculated by Chi-square 
test, n.s., not significant; d.f. = 2; do, days-old. Data in (a) are 
pooled from at least 2 independent experiments, as well as 
observations derived from continuous mouse breeding. (b,c) 
Gross appearance of wild-type and ringless embryos at e14 (b) 
and e19 (c). (d) LFB-CV staining of lumbar neural tube of e19 
embryos. Scale bar, 500 µm. Data are representative of at least 
two repeated experiments. 
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deleted preterm pups by Periodic acid-Schiff (PAS) staining and revealed 
aberrant glycogen accumulation and atrophic skeletal muscles (Figure 3.5.a) 
associated with pulmonary dysfunction demonstrated by abnormal alveoli 
structures (Figure 3.5.b,c) and reduced aerated tissue area (Figure 3.5.d) in 
the lung. Taken together, these data point to the loss of ROQUIN RING activity 
as the cause of developmental defects including an atrophic fetal diaphragm 
likely to be a major causative factor of intrapartum and neonatal terminal 
respiratory distress. 
 
3.2.3. ROQUIN RING deletion does not severely perturb thymic 
development nor CD4+ T cell peripheral homeostasis in Tringless mice 
Without viable adult ringless homozygotes, examination of ROQUIN RING-
dependent mature T cell immune responses was alternatively feasible in 
Tringless mice (section 3.2.1.). Tringless mice were physically healthy in 
appearance from birth and were maintained on a Rc3h1 exon 2 lox/lox 
background bred with only one Cre-expressing parent. 
 
We first sought to determine the role of ROQUIN RING activity in T cell 
development by examining thymocytes from 8-12 week-old Tringless mice using 
flow cytometry. ROQUIN RING deleted thymocytes were found to be largely 
comparable to floxed wild-type controls, with the frequency of single-positive 
CD4 and single-positive CD8 cells unaltered (Figure 3.6.a). Similarly, among 
the single-positive CD4 population, there were no significant abnormalities in 
the percentages of IL-2R!/CD25high FOXP3-expressing thymic Tregs (Figure 
3.6.b) nor with TCR !-chain surface expression (Figure 3.6.c). The proportions 
of CD4+ T cells in peripheral blood (Figure 3.6.d) and spleens (Figure 3.6.e)  
 43 
 
 
 
  
Figure 3.5. Respiratory dysfunction during ringless development 
(a) PAS staining of the thoracic diaphragm from e19 embryos. Scale bar, 100 
!m. (b) High threshold micrograph analysis of e19 hematoxylin and eosin 
stained lung sections. Red arrows, alveolar septum; shaded area, aerated 
tissues; Scale bar, 200 !m. (c,d) Measurements of alveolar septal thickness (c) 
and proportion of aerated lung from total lung tissue area (d) of e19 embryos. 
Statistics were calculated by Student’s t-test. Columns, median; error bars, SD. 
Data are representative of two independent experiments. 
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Figure 3.6.  CD4
+
 T cell development in Tringless mice 
(a-f) Flow cytometric assessment of thymocyte development showing proportion 
of single positive (SP) CD4 and SP CD8 thymocytes (a), proportion and count 
of FOXP3
+
CD25
+
 thymic regulatory T cells (tTreg) from SP CD4 thymocytes (b), 
surface expression TCR! on SP CD4 thymocytes (c), frequency of CD4
+
 T cells 
in peripheral blood (d) and in spleens (e), and absolute count of splenic CD4
+
 T 
cell cells (f). Statistics were calculated by Student’s t-test. Columns, n.s., not 
significant. Data are representative of four independent experiments. 
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were also normal in Tringless mice. These data indicate that intact Tringless 
T cell development is largely intact, as  observed in mice with a T cell-restricted 
deletion of the full ROQUIN protein [126] and also in sanroque mutants 
harboring a dominant negative ROQUIN variant [45]. Nevertheless, Tringless 
largely normal splenic cell numbers (Figure 3.6.f), resemble the phenotype of 
complete ROQUIN knockout mice but diverge from the T cell hypercellularity 
and general lymphocytosis of sanroque mice. The size of Tringless spleens and 
in ringless heterozygotes was comparable to wild-type littermates (Figure 3.7.a) 
(Figure 3.7.b). This is in contrast to the robust T-dependent Icos and Infg-
associated sanroque splenomegaly, which is still seen albeit milder in 
heterozygous (+/san) mutants [45, 118, 125] and in mice with a Vav-driven 
complete ROQUIN deleted hematopoietic system [126]. 
 
In the autoimmune setting of sanroque mice, a large proportion of peripheral 
T cells expressing mutant ROQUINM199R adopt a spontaneous CD44high profile 
[45], indicative of deregulated TCR activation and differentiation from naïve 
cells. sanroque CD4+ T cells also express high levels of IFN! cytokine and 
ICOS co-receptor [45, 118, 125, 159]. Although, unrestrained accumulation of 
both IFN! and ICOS could be cooperatively contributing to the sanroque 
pathology, Lee et al. [125] demonstrated that loss of IFN! cytokine-receptor 
signalling alone was necessary to completely ameliorate multiple autoimmune 
disease indicators including, activated T and B cell hypercellularity, 
splenomegaly, and importantly, circulating ANAs. Interestingly, sanroque CD4+ 
T cells demonstrate 3-fold higher ICOS surface expression on CD44low naïve 
cells and up to 4.3-fold higher ICOS expression on CD44high activated cells 
relative to wild-type [45, 117]. By contrast, Bertossi et al. [126], showed that
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Figure 3.7.  Spleens of ROQUIN RING deficient mice 
(a) Spleens from aged-matched Tringless mice. (b) Spleens from 15 wo ringless 
heterozygous littermates. Scale bars, 10 µm. Data are representative of at least 
four independent experiments 
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absence of ROQUIN in splenic CD4+ T cells does not result in an autonomous 
expansion of a CD44high population nor self-reactivity but causes a mild 
elevation in surface expression of ICOS; roughly a 1.7-fold increase on naïve 
cells and 2.7-fold higher in activated cells relative to wild-type levels. 
 
In light of the above data, we investigated if ROQUIN RING ablation could 
significantly influence T cell homeostasis in the periphery. Flow cytometry 
analysis of peripheral blood from heterozygous (Rc3h1+/lox x Lck:Cre) and 
homozygous (Rc3h1lox/lox x Lck:Cre) Tringless mice showed no cell-autonomous 
activation of CD4+ T cells as the frequencies of CD44low and CD44high T cells 
were comparable to those seen in floxed wild-type littermates (Figure 3.8.a). 
This was despite a very mild 1.4-fold increase in ICOS surface expression in 
both CD44low and CD44high CD4+ Trin/Trin T cells in the blood (Figure 3.8.b). 
Additionally, there was no significant alteration in IFN-! cytokine expression in 
Tringless CD4+CD44high T cells when compared to littermate controls (Figure 
3.8.c). Together, these data demonstrate that ROQUIN RING loss does not 
cause spontaneous T cell hyperactivity in the periphery as otherwise observed 
in sanroque mice [45, 125], and minimally affects ICOS expression upon 
homozygous genetic deletion of the ROQUIN RING domain. 
 
3.2.4. Tfh cell formation is crippled in Tringless mice  
Given that ROQUIN RING loss did not cause a robust CD4+ T cell phenotype in 
resting Tringless mice, it was important to determine whether ROQUIN RING 
deficiency affected T cell responses against exogenous antigen. We therefore 
injected heterologous SRBC i.p. into Tringless mice and examined splenocytes 
8d later by flow cytometry [160-162]. There were no significant differences in 
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Figure 3.8.  Phenotype of ROQUIN RING deficient T cells in resting mice 
(a,b) Flow cytometric analysis of CD4
+
 T cells in the peripheral blood measuring 
the frequency of CD44
low
 and CD44
high
 subsets (a) and ICOS surface 
expression (b). Statistics were calculated by Student’s t-test, n.s., not 
significant; Dot symbols, individual mice; columns, median. (c) IFN! cytokine 
production from peripheral CD4
+
 T cells. Data are from at least four independent 
experiments. 
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the proportions of IFN!+ Th1, IL-4+ Th2, IL-17+ Th17 effector populations and in 
FOXP3+ Treg cells when compared to floxed controls (Figure 3.9). We also 
sorted Tringless CD4+CD44lowCD25! naïve T cells and primed them in vitro by 
TCR and CD28 stimulation in the presence of polarising cytokines and 
neutralising antibodies (Figure 3.10.a). We then assessed Th1, Th2, Th17 and 
induced Treg (iTreg) differentiation under these optimal conditions by measuring 
intracellular expression of key nuclear factors TBET, GATA3, ROR!T and 
FOXP3 in activated cells. At d3 maximal expression of CD4+ T effector nuclear 
factors was accomplished when compared to Th0 conditions lacking cytokine 
and antibody supplements (Figure 3.10.b). As observed in mice, cell cultures 
showed no significant deviations between Tringless and floxed wild-type Th1, 
Th2, Th17 and iTreg cells (Figure 3.10.c).  
 
Unlike the non-follicular CD4+ effector T cells, the splenic proportion of 
CD4+PD-1highCXCR5high Tfh cells was significantly diminished in Tringless mice 
(Figure 3.11.a). This was associated with lower total Tfh cell counts (Figure 
3.11.b). Since Tfh cells are important for the induction and maturation of GCs, 
we examined the frequency of specialized B cells of the GC which highly 
express FAS receptor (CD95) and selectively bind GL-7 monoclonal antibody. 
GC B cells were found at a lower frequency (Figure 3.11.c) and at reduced 
numbers (Figure 3.11.d) in Tringless mice which points to insufficient T-
dependent help in a T cell-restricted ROQUIN RING deletion model. To 
measure the provision of T-dependent B cell-helping signals in these 
immunised Tringless mice, we examined intracellular IL-21 cytokine by flow 
cytometry in CD4+ T cells after ex vivo stimulation with PMA and ionomycin. In 
ROQUIN RING deficient T cells, we detected a significant decrease in the  
 50 
 
 
  
Figure 3.9.  Phenotype of ROQUIN RING deficient T cells in immunised mice 
Flow cytometric analysis of effector T cells in mice d8 post-SRBC immunisation 
showing the proportion of IFN!
+
 Th1, IL4
+
 Th2, IL-17
+
 Th17 and of 
FOXP3
+
CD25
+
 Treg cells from splenic CD4
+
 T cells. Statistics were calculated 
by Student’s t-test, n.s., not significant; Dot symbols, individual mice; columns, 
median. Data are representative of at least four independent experiments. 
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Figure 3.10. ROQUIN RING deficient CD4
+
 T cell differentiation in vitro 
(a,b) Cell culture assay on naïve T cells activated by dual coated anti-CD3 and 
anti-CD28 beads under Th1, Th2, Th17 or iTreg polarising conditions and 
analysed d3 by flow cytometry (a) to measure expression of Th transcription 
factors in CD25
+
CD69
+
 activated T cells and on FOXP3
+
 activated T cells for 
iTreg cultures (b). Statistics were calculated by Student’s t-test, n.s., not 
significant; dot symbols, individual mice; columns, median. Data are from one 
experiments. 
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Figure 3.11. Analysis of ROQUIN RING deficient Tfh cells 
(a-d) Flow cytometric analysis of d8 post-SRBC immunised mice showing the 
frequency (a) and absolute splenic cell count (b) of PD-1
high
CXCR5
high
 Tfh cells 
from total CD4
+
 T cells, and the proportion (c) and splenic cell count (d) of 
GL7
high
FAS
high
 GC B cells from total B220
+
 B cells. Statistics were calculated by 
Student’s t-test, dot symbols, individual mice; columns, median. Data are 
representative of at least four independent experiments. 
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frequency of IL-21-producing CD44high T cells (Figure 3.12). We also found a 
subtle decrease in the splenic CD4+CD44high compartment of SRBC injected 
Tringless mice that may reflect a preferential lack of antigen-experienced Tfh 
cells (Figure 3.13.a). Furthermore, as we had previously observed in T cells 
from unimmunised mice, mildly elevated ICOS expresison on the surface of 
Tringless CD4+ T cells was maintained after SRBC immunisation (Figure 
3.13.b). 
 
In Vav:Bcl2 mice, hematopoietic system-wide transgenic expression of anti-
apoptotic BCL-2 presents with CD4+ T cell-driven spontaneous GC formation, 
splenomegaly and multi-organ lymphocyte infiltration that eventually lead to 
lupus-like glomerulonephritis and follicular lymphoma [136]. These 
immunopathologies were shown to be age-dependent, especially the 
histological detection of deregulated splenic GCs which do not appear in 6-8 
week-old Vav:Bcl2 mice but are detected by 18 weeks of age. In sanroque 
female mice, GCs and autoantibodies are detected by 6 weeks of age [45, 136]. 
Taking advantage of the delayed Vav:Bcl2 GC expansion and given the 
absence of a robust T cell hyperactivation and Tfh accumulation in resting or 
immunised Tringless mice, we tested if ROQUIN RING loss could accelerate 
the CD4+ T cell-dependent pre-malignant GC hyperplasia of Vav:Bcl2 
autoimmune mice. In Vav:Bcl2 mice crossed to Tringless, we found a signficant 
reduction in Tfh cells (Figure 3.14.a) which corresponded with a lower GC 
B cell response (Figure 3.14.b). However, this did not correspond to a 
difference in spleen size (Figure 3.14.c) or in titres of circulating ANAs (Figure 
3.14.d). Therefore, in the Bcl2 transgenic model of systemic autoimmunity, T 
cell ROQUIN RING deletion does not further augment autoimmune-associated  
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Figure 3.12.  IL-21 production by ROQUIN RING deficient T cells 
Flow cytometric analysis of mice 8 d after SRBC immunisation 
showing the proportion of IL-21
+
CD44
high
 effectors from total CD4
+
    
T cells in the spleen. Statistics were calculated by Student’s t-test, 
dot symbols, individual mice; columns, median. Data are 
representative of two independent experiments. 
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Figure 3.13. Phenotype of ROQUIN RING deficient 
T cells in SRBC-immunised mice 
(a,b) Flow cytometric analysis of splenic CD4
+
 T cells 
in mice 8d post-SRBC immunisation measuring the 
frequency of CD44
low
 and CD44
high
 subsets (a) and 
ICOS surface expression (b). Statistics were 
calculated by Student’s t-test, n.s., not significant; dot 
symbols, individual mice; columns, median. Data are 
representative of at least four independent 
experiments. 
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Figure 3.14.  Effects of T cell ROQUIN RING loss on virulent GCs of 
Vav:Bcl2  mice 
(a-d) Tringless mice were crossed to Vav:Bcl2 transgenic animals 
and sacrificed at 8-12 wo for the analysis of the frequency and 
splenic cell counts of PD-1
high
CXCR5
high
 Tfh cells from total CD4
+
     
T cells (a) and GL7
high
FAS
high
 GC B cells from total B220
+
 B cells (b). 
(c) Representative spleens from aged-matched mice. Scale bars, 10 
µm. Data are representative of two independent experiments. (d) 
ELISA-based measurements of ANAs in peripheral blood. Statistics 
were calculated by Student’s t-test, n.s., not significant; dot symbols, 
individual mice; columns, median. Data in panel d are pooled from 
two independent experiments. 
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GC lymphocyte populations nor the presentation of common disease markers 
for humoral autoimmunity.  
 
Having examined Tringless T cell responses, their induction upon SRBC 
immunisation and their behaviour in the autoimmune-prone Bcl2 transgenic 
background, we next examined whether Tringless T cells could mount an 
antigen-specific Tfh cell response to an infectious pathogen. We infected 
Tringless and littermate control mice with the single-stranded RNA Lymphocytic 
choriomeningitis virus (LCMV), which predominantly yields LY6Chigh Th1 and 
LY6Clow Tfh virus-specific effector cells in mice [163, 164] and at d10 post-
infection, we analysed the splenic GC response by flow cytometry. Tfh cells 
from total CD4+CD44high T cells (Figure 3.15.a) or tetramer-stained virus-
specific CD4+GP66-77+ T cells (Figure 3.15.b) were identified by their high 
expression of surface PD-1 and CXCR5 which coincidided with low LYC6 and 
PSGL1 surface expression. We found that T cell ROQUIN RING deletion 
caused a significantly lower frequency of total PD-1highCXCR5high Tfh cells 
(Figure 3.15.c) and virus-specific PD-1highCXCR5high Tfh cells (Figure 3.15.d). 
Total Tfh cells displayed a 75 percent reduction in numbers (Figure 3.15.e) and  
virus-specific Tfh cell numbers were reduced by 86 percent (Figure 3.15.f) in 
Tringless mice compared to floxed wild-type littermates. As expected, a smaller 
Tringless Tfh cell population was associated with a decrease in BCL6 
expression in virus-specific CD4+ T cells (Figure 3.15.g), which were unable to 
support a robust ROQUIN RING sufficient GC B cell response (Figures 3.15.h 
and 3.15.i). Together, the data demonstrate that ROQUIN RING deficient CD4+ 
T cells fail to form protective Tfh cells required for an optimal GC response 
against a replicative pathogen. 
 58 
  
Figure 3.15. ROQUIN RING deleted T cell response to LCMV infection 
(a-i) Tringless mice were infected with LCMV and sacrificed 10 d later for the 
flow cytometric analysis of total Tfh cells gated from CD4
+
CD44
high
 T cells (a) 
and virus-specific Tfh cells gated from CD4
+
GP66-77
+
 T cells (b). The frequency 
of total (c) and tetramer-stained virus-specific (d) PD-1
high
CXCR5
high
 Tfh cells 
were determined and splenic cell counts of PD-1
high
CXCR5
high
 Tfh cells from 
total CD4
+
 T cells (e) and virus-specific (f) CD4
+
 T cells were calculated.         
(g) Representative histograms displaying BCL6 expression in virus-specific 
CD4
+
GP66-77
+
 T cells with median BCL6 MFI values provided. Effect of Tringless 
T cell on the frequency (h) and total splenic count (i) of GL7
high
FAS
high
 GC B 
cells from total B220
+
 B cells was analysed. Statistics were calculated by 
Student’s t-test, n.s., not significant; dot symbols, individual mice; columns, 
median. All data depicted (a-i) were generated, analysed and kindly provided by               
Dr. I. Parish. Data are pooled from three independent experiments. 
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3.3. Discussion 
The T cell immunomodulator ROQUIN contains multiple distinct domains with 
incompletely known functional attributes. A Met199 to Arg substitution in the ROQ 
domain of ROQUIN leads to virulent Tfh cell-mediated systemic autoimmunity in 
sanroque mutant mice. Whether the highly conserved RING finger adjacently 
positioned amino terminal to the ROQ domain in ROQUIN is linked to the 
sanroque T cell phenotype is unclear given no reports on the role of ROQUIN 
RING function in vertebrates.  
 
In this chapter, we found that homozygous germline deletion of the ROQUIN 
RING domain in mice results in multiple developmental defects leading to 
perinatal lethality. For a more extensive report of the heterozygous ringless 
phenotype and the effects of T cell ROQUIN RING haploinsufficiency (Trin/+), 
refer to J. Fitch (2009, Honours Thesis). Immunological analyses of adult T cell 
responses were incompatible with the early onset lethality of ringless mice, 
nonetheless, major insights were gained into how ROQUIN RING loss could 
solely be driving the strikingly similar and unexplained survival defect of 
complete Rc3h1 null newborns reported by Bertossi et al. (2011) [126]. Both 
ringless and Rc3h1 null embryos and/or neonates develop neural tube 
malformations and respiratory defects linked to early mortality. Analysis of 
pregnant ringless females also revealed undersized fetuses. Perinatal lethality 
associated with significant fetal growth restriction has been documented in 
several other RING-type E3 enzyme knockout mouse strains, including deletion 
of Fbxo45 [165], Mib1 [166], Traf2 [167] as well as Stub1 (also called Chip) 
[168], encoding an E3 ligase harbouring a modified RING domain called a U-
Box motif. Similar to ROQUIN RING deleted fetuses, Mib1 deficiency causes 
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early defective neural tube closure at e9.5 [166]. Also, Fbxo45 deleted pups 
present with respiratory failure 30 min after birth most likely caused by 
abnormal neuromusculature of the thoracic diaphragm [165]. 
 
Further to the early developmental effects caused by germline ROQUIN RING 
deletion, this chapter focuses on the involvement of the ROQUIN RING domain 
in CD4+ T cell immune homeostasis and activation. Could deletion of the 
ROQUIN RING finger recapitulate the spontaneous immunogical phenotype 
observed in sanroque mice? In resting Tringless mice, unrestrained effector 
T cell responses linked to systemic autoimmunity were not observed. This 
stands in stark contrast to our initial hypothesis (section 1.5.i) and opposes the 
phenotype of sanroque mice. 
 
It was unexpectedly found that T cell ROQUIN RING deletion selectively 
cripples Tfh formation while leaving unaffected other CD4+ effector T cells, 
namely Th1, Th2, Th17 and Treg cells. By comparing the robust Trin/Trin  T cell 
phenotype with that of the non-penetrant Lck:Cre-expressing Trin/+ haplotype 
(Rc3h1lox/+ x Lck:Cre) displaying completely healthy T-dependent GC responses 
(described by J. Fitch, 2009, Honours Thesis), we concluded that Tfh-specific 
deficiency was not a result of potential Cre-mediated genotoxicity [169] but 
caused by T cell ROQUIN RING loss. Additionally, we observed normal thymic 
development in Tringless which did not reflect the thymocyte-depleting effects of 
aberrant Lck:Cre activity previously characterised by Shi and Petrie [170]. 
 
It is possible that T cell priming signals, such as TCR induction, CD28 
costimulation and the cytokine milieu, that are at minimum sufficient to direct 
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non-follicular effector T cell differentiation, do not feed directly into ROQUIN 
RING signalling for Tfh cell lineage commitment. The Tfh cell immunodeficiency 
in Tringless mice, contingent upon GC induction by infection, SRBC injection or 
Bcl2 overexpression, suggests that the ROQUIN RING finger has a different 
function to the RNA-binding ROQ domain. Divergent mechanistic actions of the 
RING and ROQ regions may explain the polarised T cell dysfunction in 
Tringless and sanroque mice. Further examination of the involvement of 
ROQUIN RING signalling within known Tfh cell intracellular signalling networks 
could reveal a basis for why the RING domain preferentially acts on Tfh cells. 
 
Retention of the ROQ and C3H1 domains of ROQUIN in Tringless mice, which 
are required for RNA regulation of Tfh cell-polarising transcripts and maintaining 
immune tolerance, is likely to contribute to the maintenance of Tringless T cell 
homeostasis and prevent autoimmunity. This is evidenced by little disruption in 
expression of the bone fide post-transcriptional ROQUIN target ICOS, which is 
expressed at profoundly higher levels in sanroque mutant mice and in Bertossi 
et al.’s [126] complete ROQUIN deficient mice, as fold-change relative to wild-
type controls. Given that no reduction in ICOS expression was detected, 
reduced ICOS-mediated GC migration [16] would be an unlikely cause of Tfh 
deficiency in Tringless. However, undisturbed RNA-destabilising activity of 
RING-deficient ROQUIN in Tringless T cells would alone not be sufficient to 
significantly reduce Tfh cell formation but rather assist in maintaining normal 
T cell differentiation. In Tringless T cells, intact ROQUIN RNA regulatory 
function may therefore be acting secondary to the loss of ROQUIN RING 
signalling, which is yet to be characterised. 
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In view of the T cell-restricted ROQUIN RING deletion in Tringless compared to 
sanroque mice that harbour a dominant Rc3h1 mutation in all cell lineages, it is 
also possible that T cell extrinsic factors absent in Tringless are required to 
potentiate T cell hyperactivity and loss of tolerance. For instance, in sanroque 
intercrossed with Obf1-/- mice, autoreactive GC-independent IgM responses 
have been observed [171], and in macrophages, ROQUIN ROQ-mediated RNA 
regulation was shown to be critical for limiting TNF! over-production leading to 
myeloid hyperplasia and autoinflammation [45, 116]. Furthermore, Betrossi et 
al. documented a complete disruption of normal histological architecture in 
Rc3h1!/! spleens [126]. It is unknown whether this also occurs in Tringless mice 
but could prevent cellular interactions necessary for spontaneous Tfh-GC 
reactions. Histological examination of GCs in Tringless mice was not addressed 
but these environmental factors, combined with T cell-instrinsic functional 
deficiencies in IL-21 and BCL6 expression leading to crippled Tfh cell 
development, elicited only upon immunisation with innocuous antigen or viral 
infection, could be contributing to absence of autoreactivity in Tringless mice.  
 
Crossing Tringless with Vav:Bcl2 mice did not augment T cell-dependent BCL2-
driven autoimmne GC pathology. This augmentation was previously achieved 
by over-expressing the Th1/Th2 cell-limiting histone methyltransferase EZH2 
[172], which further compounded the spontaneous GC hyperplasia, 
lymphomagenesis and splenic enlargement of a Vav:Bcl2 immune system 
[173]. Instead, T cell ROQUIN RING loss resulted in a reduction of Tfh cell and 
GC B cells in Vav:Bcl2 mice, reproducing the Tringless phenotype post-SRBC 
immunisation and in response to LCMV challenge. ROQUIN RING deletion in 
T cells was also capable of uncoupling the positive association between Tfh/GC 
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B cell accumulation and the production of ANAs. Indeed, ANAs were still 
present in Tringless x Vav:Bcl2 mice despite lack of Tfh cell accumulation. This 
may be due to an extrafollicular orgin of autoreactive B cell responses in the 
Vav:Bcl2 strain. As demonstrated in various other autoimmune mouse models, 
including sanroque mutants, Fas knockouts, BXSB-Yaa and NZB/NZW mice as 
well as collagen-induced arthritic mice [42, 45, 125, 174, 175], unrestricted Tfh 
accumulation is associated with spontaneous self-reactive GCs. This is 
consistent with observations that Tfh cells may be playing a central role within 
GCs as a limiting factor in facilitating optimal GC B cell tolerance and antigen 
recognition [176-178]. As the GC largely consists of maturing B cells, Tfh cells 
in narrow numbers are best at maintaining a selective pressure for B cell 
competition to gain Tfh help, favouring the survival of antigen-responsive GC 
B cell clones at the expense of their self-reactive counterparts. Deregulated 
expansion of Tfh cell numbers beyond a pathogenic threshold may underlie a 
breach in tolerance whereupon excess provision of Tfh cell-derived positive 
selection signals to “forbidden” autoreactive GC clones could lead to their 
pathological survival and differentiation into autoantibody secreting cells [42]. 
 
Taken together, the results definitively set the phenotype of ROQUIN RING 
deleted T cells apart from that which is observed in sanroque, especially in their 
inability to display a profile for spontaneous activation. These results point to 
Tringless as a unique mouse model for ROQUIN dysfunction and Tfh cell 
immunodeficiency, and identify novel molecular mechanisms capable of 
controlling Tfh cell responses. 
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chapter four 
4. Molecular examination of ROQUIN RING  
signal transduction 
 
4.1. Preamble 
4.1.1. RING-mediated ubiquitination 
Ubiquitination is a highly conserved ATP-dependent form of post-translational 
signalling within cells that is important for the regulation of a vast range of 
biological processes. It results in the covalent attachment of ubiquitin, at its 
carboxy terminus, to a target cellular protein. 
 
The process of ubiquitination consists of a three-step catalytic cascade 
orchestrated by an E1, E2 and then E3 enzyme [179]. Importantly, the terminal 
E3 enzyme (also called E3 ubiquitin ligase) confers substrate specificity in the 
reaction, acting as a molecular liaison in mediating ubiquitin transfer from the 
donor E2 enzyme holding an activated ubiquitin molecule to a specific acceptor 
lysine on a target protein substrate that forms a covalent bond with ubiquitin. 
Given the direct and interface-specific interaction between E3 enzymes and 
their target protein, E3 ligases often extend ubiquitin attachments on target 
proteins with additional ubiquitin molecules forming a multimeric or polyubiquitin 
side chain. It has been classically viewed that polyubiquitin chains, minimally 
consisting of four monomers linked by their acceptor Lys48 residue, act as 
trafficking signals for their conjugated protein substrates to undergo 
proteosomal degradation [180-182]. In contrast, single ubiquitin conjugation 
(called monoubiquitination) or Lys63-linked polyubiquitin chains typically mediate 
non-proteolytic alterations in their target’s cellular function, localisation or affinity 
towards binding partners [183, 184]. Recent observations in vivo however have 
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revealed that E3 ligases may also target all seven ubiquitin Lys residues (Lys6, 
Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63) as well as the amino terminal Met1 as 
acceptors in unconventional chain linkage formation [185]. The specific 
signalling function of these unconventional polyubiquitin chains remains 
incompletely understood. 
 
There are three classes of E3 ubiquitin ligases. These are categorised 
according to their conserved catalytic structural domains and the mode of 
ubiquitin transfer from donor E2 enzyme to acceptor substrate [179]. Notably, 
E3 ligase members of all three classes are capable of assembling diverse 
ubiquitin linkages. Members of the HECT and RBR classes require a 2-step 
reaction process whereby ubiquitin is first transferred from donor E2 to an 
intrinsic catalytic cysteine residue on the E3 ligase before ubiquitin is then 
directed to the target substrate [186, 187]. This is in contrast to the RING family 
of E3 ligases that simultaneously recruit donor E2 and its target protein to 
facilitate ubiquitin transfer directly from donor to acceptor [188]. RING-type E3 
ubiquitin ligases therefore do not formally contain an active site as they do not 
inherently catalyse ubiquitin conjugation to the substrate protein. Instead, they 
harbour a conserved RING domain important for contacting donor ubiquitin-E2 
conjugates [179]. RING domains are 40-60 aa in size and typically consist of a 
C3HC4 zinc finger (also called RING finger) coordinated by two structural zinc 
cations. In synergy with the RING domain, additional domains on the E3 protein 
participate in the reaction, especially in recruiting substrate for ubiquitin-
dependent post-translational modification. 
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4.1.2. The ROQUIN RING domain 
Recent crystallography data on the ROQUIN amino terminal protein revealed in 
detail a configurational basis for its ROQ-mediated RNA-binding capacity [111-
113, 124]. In addition, a conserved RING domain was visualised adjacently N-
terminal to, and independent of, the ROQ domain [124]. The ROQUIN RING 
domain was found to assume a canonical tertiary fold resembling those of other 
members of the RING-type E3 ligase superfamily. Two zinc-chelating pockets 
were detected, one consisting of four cysteine ligands (Cys14, Cys17, Cys38, 
Cys41), and another with two cysteines, a histidine and an aspartate (Cys33, 
His35, Cys50, Asp53) as its zinc-coordinating residues. A core aspartate-
containing C3HC3D RING domain is uncommon but does occur in other E3 
enzymes, for instance in NF!B-inducing TRAF family members, TRAF4 [189], 
TRAF5 [190], TRAF6 [151] and TRAF7 [191]. 
 
Given the conforming tertiary structure of the ROQUIN RING domain and 
having previously established its physiological importance, particularly in 
specifying Tfh cell formation in vivo (section 3.2.4.), we set out to identify a 
molecular target for ROQUIN RING signalling in the context of characterising its 
intracellular mechanism of action.  
 
4.2. Results 
4.2.1. Qualifying ROQUIN as a regulator of FOXOs  
Multiple indicators pointed to members of the FOXO family of nuclear factors as 
potential targets of the putative E3 ligase function of ROQUIN. Both ROQUIN 
and FOXOs are highly conserved, and in C. elegans the ROQUIN orthologue 
RLE-1 was found to interact with, polyubiquitinate and facilitate the proteasomal 
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degradation of DAF-16, the ancestral representative of the mammalian FOXO 
family of nuclear factors [131]. Similarly, FOXO proteins are known to undergo 
negative regulation by ubiquitin-mediated post-translational modification 
facilitated by E3 enzymes such as MDM2 and SKP2 [192]. FOXOs represent 
important terminal signal transducers of the PI3K signalling pathway, which is 
known to be important for Tfh cell differentiation [97, 98]. Given these links 
between ROQUIN’s ubiquitin ligase activity on the FOXO-related family member 
in C.elegans, and the putative link between FOXO, Tfh cells and ROQUIN 
function, we decided to test if ROQUIN and FOXOs could bind to each other via 
immunoprecipitation upon combined over-expression in HEK293T cells. We 
could not detect any protein interaction when either ROQUIN or FOXO3a, the 
most highly conserved FOXO family member, were pulled down (Figure 4.1.a). 
 
Previously, FOXO3a was shown to be required for limiting CD4+ T cell 
autoactivation in Foxo3a knockout 129S1 mice [158], a molecular role 
consistent with the C57BL/6 Tringless T cell phenotype (sections 3.2.3. and 
3.2.4.). In contrast however, Dejeen et al. [193] noted that in the C57BL/6 and 
FVB/NJ mouse backgrounds, spontaneous CD4+ T cell activation does not 
result from Foxo3a deletion, likely due to compensation by its lymphoid-specific 
paralogue Foxo1. We therefore tested ROQUIN-FOXO1 binding but could not 
detect positive immunoprecipitation between ROQUIN and FOXO1 (Figure 
4.1.b). These data were consistent with findings by Dr. V. Athanasopoulos and 
Prof. R. Saint that demonstrated no detectable immunoprecipitation between 
ROQUIN and FOXO orthologues of Drosophila melanogaster, when over-
expressed in HEK293T cells with protein tags of various size and fusion sites 
(Roq-GFP and V5-Foxo; unpublished data). Together, these results suggest  
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Figure 4.1.  Identification of ROQUIN protein binding partners 
(a-d) M. musculus V5-ROQUIN was transfected into HEK293T cells along with 
H. sapiens FLAG-FOXO3a (a), GFP-FOXO1 (b), TP53-MYC-FLAG (c), or 
AMPK!1-GFP (d) to screen for interactions between tagged proteins by 
immunoprecipitation of cell lysates prepared 2d post-transfection. Data are 
representative of two independent experiments. *rabbit polyclonal control IgG 
exhibiting non-specific affinity for high molecular weight proteins; IB, 
immunoblot; IP, immunoprecipitated. Data are representative of three 
independent experiments. 
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functional divergence between RLE-1 and its descendants Roq and ROQUIN in 
higher organisms. 
 
4.2.2. Identification of a ROQUIN RING cellular substrate 
In light of the absence of a ROQUIN-FOXO protein interaction, we began to 
screen for ROQUIN protein interaction partners that might parallel FOXO 
function in the PI3K pathway. The p53 tumor suppressor protein is directly 
regulated by AKT-MDM2 downstream of PI3K signals [194, 195]. Furthermore, 
p53 interacts and colocalises with canonical stress granule markers G3BP1 and 
G3BP2 [196] that have been shown to associate with ROQUIN [115]. Analysis 
of the ROQUIN protein sequence using the MyHits Motif Scan online database 
(http://myhits.isb-sib.ch/cgi-bin/motif_scan), revealed a putative p53-binding 
moiety in ROQUIN (aa 183-196; Pfam Acc. PF01696). However, we excluded 
p53 as a ROQUIN interacting partner by lack of reciprocal immunoblot detection 
from coimmunoprecipitation assays (Figure 4.1.c). 
 
The intracellular bioenergy-sensing enzyme, adenosine monophosphate-
activated protein kinase (AMPK) acts as an upstream activator of FOXO3a 
[197] and promotes p53 activity [198] as part of its overall antagonism of 
intracellular PI3K signals [199]. Like p53, AMPK has also been shown to bind 
G3BP1 and G3BP2 [200]. Interestingly, AMPK over-expression in nematode 
worms is known to extend lifespan [201], an observation consistent with the 
phenotype of worms lacking the ROQUIN orthologue RLE-1 [131]. Because the 
AMPK catalytic !1 subunit is specifically expressed and activated within T cells 
but not its highly homologous !2 isoform [201], we screened AMPK!1 as a 
ROQUIN interacting partner and found that after over-expression in HEK293T 
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cells, ROQUIN and AMPK!1 showed weak but reciprocal interactions upon 
immunoprecipitation of either protein (Figure 4.1.d). Two-way pull down of 
ROQUIN and AMPK!1 was validated by immunoprecipitation of protein lysates 
from HEK293T cells after single transfection of each cDNA construct to control 
for non-specific binding to precipitating antibody or resin (Figure 4.2.a). We 
next determined if ROQUIN and AMPK!1 interacted in situ by conducting a 
proximity ligation assay (PLA) on primary C57BL/6 mouse embryonic fibroblast 
(MEF) cells under resting and oxidative stress conditions with transient arsenite 
exposure. We found that endogenously expressed ROQUIN and AMPK!1 
proteins localised in very close molecular proximity in both resting and arsenite-
stressed primary MEFs compared to control PLAs. These control PLAs 
measured “false” interactions between endogenous AMPK!1 and non-
expressed GFP (Figures 4.2.b and 4.2.c); the latter detected by anti-GFP 
immunostaining (Figure 4.2.d). Moreover, to confirm the immunological 
relevance of a ROQUIN-AMPK protein interaction, we were able to 
coimmunoprecipitate endogenous ROQUIN and AMPK!1 in the mouse 
T lymphoblast cell line EL4 (Figure 4.2.e). 
 
Upon ectopic expression in HEK293T cells, ROQUIN colocalised with AMPK!1 
diffusely or in fine cytoplasmic speckles in resting cells, and within larger 
cytoplasmic granules upon induction of oxidative stress (Figure 4.3.a). We also 
observed colocalisation of endogenous AMPK!1 within ROQUIN+ cytoplasmic 
granules in arsenite-treated primary MEFs (Figure 4.3.b). Importantly, this 
immunofluorescence detection of endogenous AMPK!1 was achieved using an 
AMPK!1-specific antibody displaying no cross-reactivity towards the AMPK!2 
subunit when ectopically expressed in HEK293T cells (Figure 4.3.c). Taken  
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Figure 4.2.  Molecular interaction between ROQUIN and AMPK!1 
(a) Immunoprecipitation of V5-ROQUIN and AMPK!1-GFP over-expressed in 
HEK293T cells. Data representative of four independent experiments. (b) PLAs 
on C57BL/6 MEFs showing interactions between endogenous ROQUIN and 
AMPK!1 in resting conditions (ROQUIN:AMPK!1) and after exposure to 1 mM 
arsenite (+AS, ROQUIN:AMPK!1). Control PLAs (GFP:AMPK!1) detecting 
non-expressed GFP and endogenous AMPK!1 background are also displayed. 
Blue, DAPI stained nuclei; Red, ligation events, Scale bar, 20 mm. (c) 
Quantitative analysis of PLAs showing mean ligation events per cell (nucleus) 
for each field of view on a confocal microscope. Individual dots represent a 
single field of view; bar per column represents the sample mean. Statistics were 
calculated by one-way ANOVA with Bonferroni’s multiple comparisons test after 
log transformation of ratio values, n.s., not significant. Data are representative 
of three independent experiments. (d) Control PLAs (GFP:AMPK!1; panels b 
and c) used anti-GFP antibody titrated by immunostaining transfected HEK293T 
cells expressing AMPK!1-GFP. Blue, DAPI stained nuclei; Red, anti-GFP stain; 
Green, anti-AMPK!1 stain; Scale bar, 50 µm. (e) Immunoprecipitation of 
ROQUIN and AMPK!1 endogenously expressed in EL4 cells. IB, immunoblot; 
IP, immunoprecipitated. Data included in panels b-d were obtained with the 
assistance of Dr. V. Athanasopoulos. 
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Figure 4.3. Subcellular localisation of ROQUIN and AMPK!1 
(a) Colocalisation of V5-ROQUIN and AMPK!1-GFP ectopically expressed in 
resting (top) and 1 mM arsenite (AS)-treated (bottom) HEK293T cells. Data are 
representative of three independent experiments. (b) Colocalisation of 
endogenous ROQUIN and AMPK!1 in primary MEFs post-arsenite treatment. 
Data are representative of three independent experiments. (c) Detection of 
AMPK!1 by immunostaining primary MEFs (as shown in panel b) was achieved 
using an !1 isoform-specific immunofluorescence-grade antibody that showed 
negligible cross-reactivity with AMPK!2-GFP expressed in HEK293T cells. All 
data depicted (a-c) were generated, analysed and kindly provided by Dr. V. 
Athanasopoulos. 
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together with our coimmunoprecipitation and PLA findings, these data indicated 
that ROQUIN can colocalise and directly interact with the !1 subunit of AMPK 
and that under physiological conditions, the two proteins can form a stable 
complex. 
 
4.2.3. A molecular basis for ROQUIN RING-AMPK signalling 
AMPK!1 is a constituent of the AMPK complex containing three core subunits: 
a single ! catalytic subunit with a regulatory ! and ! subunit that together 
configure into an obligate !"# heterotrimeric kinase [202]. In mammals, each 
core subunit is derived from multiple tissue-specific isoforms: !1 or !2; "1 or 
!2; "1, "2 or !3 isoforms.  In response to depleted intracellular ATP bioenergetic 
reservoirs that reciprocally lead to high levels of AMP, the AMPK complex 
undergoes a conformational change, becoming a substrate for activation by 
kinases LKB1 or CaMKK. In turn, active AMPK phosphorylates a plethora of 
downstream targets to coordinate cellular lipid and glucose metabolism, and 
limit cell growth [199]. Targets of AMPK include Acetyl CoA Carboxylase (ACC), 
a key enzyme in fatty acid synthesis and oxidation, and components of the 
mTOR signalling pathway, RAPTOR and Tuberous Sclerosis Complex 2 (TSC2) 
that are important for coordinating protein synthesis and expression of 
tumorigenic factors like HIF1 and c-MYC.  
 
To determine the functional consequence of a ROQUIN-AMPK!1 interaction, 
we measured and compared AMPK activity in Tringless and wild-type T cells. In 
contrast to wild-type cells, ROQUIN RING-deficient CD4+ T cells displayed 
increased in vitro phosphorylation of the prototypic AMPK target, SAMS 
peptide, derived from the ACC protein sequence (Figure 4.4.a). Immunoblots of  
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Figure 4.4. AMPK activity in ROQUIN RING deficient cells 
(a) In vitro kinase assay of AMPK! in isolated CD4
+
 T cells during an anti-CD3 
with CD28 activation time-course. Data are pooled from two independent 
experiments and normalised to unstimulated wild-type (n = 5). Black columns, 
floxed wild-type; white columns, Tringless. Statistics were calculated by 
Student’s t-test, n.s., not significant; columns, mean; error bars, SEM. (b) 
Phosphoblot of endogenous ACC Ser
79
 in resting CD4
+
 T cells. Representative 
of three independent experiments. (c) Flow cytometric analysis of phospho-rS6 
Ser
235/236
 in CD44
low
 or CD44
high
 CD4
+
 T cells during anti-CD3 with CD28 
stimulation (n = 4–6). Data are representative of two independent experiments. 
(d) Phosphoblot of ACC Ser
79
 and RAPTOR Ser
792
 in primary MEFs recovered 
in complete DMEM for 3 h after treatment with 1 mM arsenite for 1 h.  IB, 
immunoblot. Measurements of CD4
+
 T cell AMPK activity in panels a and b 
were conducted, analysed and kindly provided by Dr. R. Lee-Young. 
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ROQUIN RING-deficient CD4+ T cell lysates also showed enhanced p-ACC 
phospho-protein (Figure 4.4.b). In both CD44low and CD44high CD4+ T cells 
stimulated ex vivo via CD3 with CD28 costimulation, we found lower expression 
of phospho-Ser235/236 on ribosomal protein S6 (p-rS6) (Figure 4.4.c), an 
indicator of impaired mTOR function. In addition, increased phosphorylation of 
the AMPK targets ACC and RAPTOR was observed in ringless primary MEF 
lysates (Figure 4.4.d). Thus, we concluded that the ROQUIN RING domain is 
required to negatively regulate AMPK!1 activity. 
 
Given the important role of RING domains in facilitating protein substrate 
ubiquitination (section 4.1.1.), we next tested if the regulation of AMPK activity 
by ROQUIN was a result of RING-mediated AMPK ubiquitination. By over-
expression of ROQUIN with AMPK!1 and ubiquitin in HEK293T cells, we found 
that absence of the ROQUIN RING domain did not alter AMPK ubiquitination, 
irrespective of the position and size of AMPK!1 fusion tags (Figures 4.5.a and 
4.5.b).  
 
During the course of these assays, we detected monoubiquitination of 
endogenous ROQUIN in the mouse EL4 T cell line (Figure 4.5.c). To determine 
if ROQUIN monoubiquitination was dependent on the 14.7 kDa RING finger 
deleted in ROQUIN RING deficient mice, we tested if ROQUIN could undergo 
autoubiquitination. For this, we performed ubiquitination assays in transfected 
HEK293T cells. Ubiquitin-conjugated ROQUIN was detected by 
immunoprecipitation when full-length ROQUIN was over-expressed but not 
upon over-expression of a ROQUIN133-1130 variant recapitulating the specific 
RING deletion borne by Tringless T cells (Figure 4.5.d). Also, by Coomassie 
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Figure 4.5. Ubiquitin utilisation by the ROQUIN RING domain 
(a) HEK293T cells were co-transfected with AMPK!1-GFP, HA-Ubiquitin and 
full-length V5-ROQUIN or RING-deleted V5-ROQUIN
133-1130
 and analysed 2 d 
later for HA-ubiquitin attachment to immunoprecipitated AMPK!1-GFP. (b) An 
alternate AMPK!1-MYC-FLAG construct was transfected into HEK293T cells 
and ubiquitination assays (as described in panel a) were performed on 
immunoprecipitated AMPK!1-MYC-FLAG. (c) Ubiquitin immunoblot of 
endogenous ROQUIN immunoprecipated from EL4 cells. (d) HEK293T cells 
were co-transfected with HA-Ubiquitin and V5-ROQUIN or RING-deleted       
V5-ROQUIN
133-1130 
and analysed 2 d later for HA-ubiquitin attachment to 
immunoprecipitated V5-ROQUIN constructs. IB, immunoblot; IP, 
immunoprecipitated. (e) In vitro autoubiquitination assay for ROQUIN wild-type 
peptide (residues 1–484) and RING finger deleted peptide (residues 145–484). 
Five consecutive lanes show the extent of ROQUIN autoubiquitination of the 
same in vitro reaction at 0, 1, 2, 4, and 16 h. Data are representative of three 
independent experiments. Dr. J. Babon generated, analysed and kindly 
provided data from in vitro autoubiquitination assays shown in panel e. 
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staining of PAGE-separated peptides from in vitro ubiquitination reactions, we 
detected a single protein band of higher molecular weight relative to ROQUIN 
peptide that formed in the presence of wild-type ROQUIN1-484 and ubiquitin 
(Figure 4.5.e). This slowly migrating band, consistent with monoubiquitin 
attachment, formed with severe delay in the absence of the RING zinc finger. A 
complete absence of this higher molecular weight ROQUIN modification was 
observed with in vitro reactions lacking ubiquitin protein. Together, our data 
suggest that the ROQUIN RING domain can facilitate autoubiquitination 
independent of residues carboxy terminal to Asp484. 
 
ROQUIN is a well-established component of cytoplasmic mRNPs foci such as 
stress granules and processing bodies [45, 114, 115, 203]. We speculated that 
ROQUIN stress granule localisation and its ability to bind AMPK within stress 
granules could be linked to ROQUIN RING-mediated AMPK repression. To test 
this, we determined whether the RING domain was required for ROQUIN 
trafficking into stress granules, using the canonical stress granule marker, 
eukaryotic initiation factor 3 (eIF3) [120]. By visualizing transfected HEK293T 
cells by fluorescence microscopy, we observed that ROQUIN133-1130 lacking the 
RING domain did not coalesce with arsenite-induced eIF3+ stress granules 
compared to full-length ROQUIN found in eIF3+ stress granules (Figure 4.6.a). 
Additionally, treatment of arsenite-stressed cells with the AMPK agonist, 5-
aminoimidazole-4-carboxamide ribonucleotide (AICAR) did not prevent full-
length ROQUIN from localising to eIF3+ stress granules. To confirm that stress 
granule exclusion was not a secondary effect of a structurally unstable 
ROQUIN1-132 deletion but rather a consequence of the loss of RING-mediated 
E3 ligase activity, a loss-of-function mutation of the first zinc-coordinating 
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Figure 4.6. ROQUIN RING-dependent stress granule trafficking 
(a) Colocalisation of ectopically expressed full-length V5-ROQUIN or     
V5-ROQUIN
133-1130
 with endogenous eIF3 in HEK293T cells stressed with 
1 mM arsenite (AS) for 1 h with or without 2 mM AICAR. Scale bar, 50 µm. 
Data are representative of three independent experiments.                      
(b) Colocalisation of ectopically expressed full length ROQUIN-GFP or 
ROQUIN
C14A
-GFP mutant with endogenous eIF3 in HEK293T cells 
stressed with 1 mM arsenite for 1 h. All data depicted (a-b) were 
generated, analysed and kindly donated by Dr. V. Athanasopoulos. 
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cysteine of the RING domain (Cys14Ala; ROQUINC14A) that typically abolishes 
E3 ligase activity of related RING-containing enzymes [139, 140] was 
introduced into HEK293T cells. ROQUINC14A ectopic expression was still able to 
facilitate de novo stress granule induction in the absence of arsenite treatment 
comparable to cells transfected with wild-type ROQUIN [114]. Nevertheless, in 
response to arsenite exposure, ROQUINC14A localisation to eIF3+ stress 
granules was significantly impaired (Figure 4.6.b). Together, the data indicate 
that an intact RING domain is required for stress granule localisation of 
ROQUIN, which is not influenced by downstream AMPK feedback. Additionally, 
we found that the ROQUIN RING domain was dispensable for ROQUIN-
AMPK!1 colocalisation within cytoplasmic granules of arsenite-treated 
transfected HEK293T cells (Figure 4.7.a). This was consistent with 
ROQUIN133-1130 retention to interact with AMPK!1 by immunoprecipitation 
(Figure 4.7.b), indicative of RING-independent ROQUIN-AMPK!1 binding. 
 
Detection of the ROQUIN-AMPK!1 complex both in the presence and absence 
of cellular stress conditions and upon loss of ROQUIN RING signalling 
suggests a highly stable physiological interaction between the proteins. We next 
sought to determine whether ROQUIN could also associate with other 
regulatory subunits of the AMPK signalling complex within cytoplasmic stress 
granules. By immunofluorescence microscopy of arsenite-stressed HEK293T 
cells co-transfected with ROQUIN and AMPK cDNA, we found that unlike the 
AMPK!1 subunit, ectopically expressed AMPK ! and ! non-catalytic subunits 
did not associate with ROQUIN+ stress granules (Figure 4.8). AMPK!2 and 
AMPK!3 exhibited generally diffuse cytoplasmic distribution. The AMPK! 
subunit, which is highly endogenously expressed in the HEK293T cell line, acts  
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Figure 4.7. ROQUIN RING-independent AMPK!1 recruitment 
(a) Colocalisation of V5-ROQUIN
133-1130
 with AMPK!1-GFP when 
ectopically expressed in HEK293T cells stressed with 1 mM arsenite 
exposure for 1 h. (b) Immunoprecipitation of full-length V5-ROQUIN 
or V5-ROQUIN
133-1130
 and AMPK!1-GFP ectopically expressed in 
HEK293T cells. Data are representative of two independent 
experiments. IB, immunoblot; IP, immunoprecipitated. All data 
presented (a-b) were generated, analysed and kindly donated by Dr. 
V. Athanasopoulos. 
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Figure 4.8. Subcellular localisation of regulatory AMPK subunits 
Protein localisation of V5-ROQUIN and carboxy terminal GFP fusion constructs 
of AMPK regulatory subunits ectopically expressed in HEK293T cells and 
analysed by immunofluorescence microscopy. Data are representative of two 
independent experiments. All data presented were generated, analysed and 
kindly donated by Dr. V. Athanasopoulos. 
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as a central scaffolding component to bind both ! and ! subunits [202]. Our 
data therefore suggests that AMPK, in its functional ternary complex, does not 
co-localise with ROQUIN in cytoplasmic stress granules. 
 
4.3. Discussion 
Post-transcriptional mechanisms for ROQUIN-mediated control of mRNA half-
life have been extensively characterised (section 1.2.3.) but to our knowledge, 
reports on the function of the E3 ligase-associated RING domain of mammalian 
ROQUIN and its involvement in intracellular signalling are currently lacking. This 
chapter identifies a molecular role for ROQUIN RING signalling in perinatal 
survival and in Tfh cell responses in vivo (section 3.2.4.). 
 
We found that ROQUIN in higher eukaryotes did not interact with FOXO 
transcription factors nor co-localise with the highly conserved FOXO3a protein 
in transfected HEK293T cells. Since RING-classed E3 enzymes specialise in 
contact-dependent recognition and recruitment of protein targets during 
intracellular ubiquitination reactions, it is unlikely that ROQUIN is a direct E3 
ligase for FOXO proteins in mammals. This surprising finding argues against 
our initial hypothesis (section 1.5.ii), which was primarily based on an early 
report on the ancestral C. elegans ROQUIN orthologue, RLE-1 facilitating 
ubiquitination of the FOXO-related target DAF-16 via a direct protein interaction 
[131]. One possible explanation for this functional divergence between ROQUIN 
and RLE-1 could lie in an evolutionary rearrangement of the carboxy terminal 
protein structure, particularly in the absence of a proximal C3H1 domain in C. 
elegans (Figure 3.1.), which is functionally critical for ROQUIN RNA binding. 
This example of speciation is also supported by gene duplications of rle-1 and 
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daf-16, both sole orthologues of mammalian Rc3h (Rc3h1 and Rc3h2) and 
Foxo (Foxo1, Foxo3a, Foxo4 and Foxo6) families, respectively. 
 
Unexpectedly, we revealed a novel regulatory role for ROQUIN RING signalling 
in directly limiting AMPK activity. By performing immunoprecipitation assays that 
detect protein interactions or protein complex subunits from a pooled population 
of cells, in addition to conducting PLA measurements of individual 1:1 protein-
protein binding events per cell, we found that ROQUIN directly interacted with 
the T cell-specific AMPK!1 subunit of the AMPK complex. The ROQUIN RING 
finger was not required for AMPK!1 recruitment but was indispensible in the 
negative regulation of AMPK signalling through AMPK!1 sequestration into 
stress granules following ROQUIN–AMPK!1 complex formation. AMPK 
activation has been heavily reported in cellular responses to various stressors, 
including hyperosmotic pressure [204], hypoxia [205], nutrient deprivation [206, 
207], heat shock and oxidative stress [208], that all result in depleted 
intracellular ATP levels. In addition, CaMKK also phosphorylates and activates 
AMPK downstream of a TCR-induced calcium influx in T cells [201]. To our 
knowledge, ours is the first characterisation of AMPK!1 packaging within stress 
granules. These granules are known to readily form upon cellular exposure to a 
range of cytopathological conditions as well as upon physiological stimulation of 
CD4+ T cells (section 1.2.3.), all known triggers of AMPK activation. 
 
We show that ROQUIN RING sequestration of AMPK!1 was not an indicator of 
AMPK !"# complex trafficking into stress granules, as the ! and ! subunits did 
not co-localise with cytoplasmic ROQUIN+ stress granules. This is unsurprising 
given previous functional studies on the central AMPK! non-catalytic subunit, 
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not only as a scaffold protein for ! and ! subunit docking [202] but also 
facilitating intracellular trafficking of the AMPK complex to lipid membranes 
[209, 210] and to cytoplasmic glycogen deposits [211]. Although ROQUIN-
independent mechanisms of AMPK complex localisation to stress granules or to 
other such cytoplasmic mRNP aggregates cannot be excluded, our results 
show that upon stress, ROQUIN can effectively induce dissociation and 
deactivation of the AMPK heterotrimeric complex by RING-mediated targeting 
of AMPK!1. This represents a novel mechanism, by which stressed cells can 
limit cell proliferation [198, 212], intiate autophagy [206, 213] or undergo 
apoptosis [214].  
 
In addition to halting protein synthesis by packaging RNA-binding proteins, 
small ribosomal subunits and stalled translation initiation factors, stress 
granules are known to block programmed cell death by sequestering key pro-
apoptotic proteins such as RACK1 [215], ROCK1 [216] and TRAF2 [217]. It is 
possible that in response to cellular stress signals, subversion of these 
signalling proteins that parallel AMPK activity, leads to transient apoptotic 
resistance to offer viable cells a tolerance threshold and recover from stressors 
while avoiding aberrant growth on account of limited mRNA translation and 
metabolic activity. Therefore, we speculate that ROQUIN RING signalling may 
be part of a cellular stress response checkpoint important in linking stress 
granule dynamics to AMPK attenuation in the regulation of cell growth and 
survival. 
 
We found that over-expression of RING-sufficient or -deficient ROQUIN did not 
facilitate AMPK!1 ubiquitination in transfected HEK293T cells, a common 
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strategy for cell-based ubiquitination assays. However, the ROQUIN RING 
domain was essential for ROQUIN autoubiquitination, which was associated 
with its localisation to stress granules. This mechanism of action has similarly 
been observed in the T cell E3 ligase TRAF6, harbouring an uncommon 
ROQUIN-like C3HC3D RING domain variant in its distal amino terminus. 
Deleting or mutating the TRAF6 RING domain at core residues concomitantly 
extinguishes autoubiquitination and trafficking of the protein to distinct 
cytoplasmic foci [218]. However, unlike ROQUIN RING ablation that causes 
abnormal localisation of ROQUIN-AMPK!1 complexes to non-stress granule 
cytoplasmic punctae in stressed cells, loss of RING-dependent 
autoubiquitination function in TRAF6 results in diffuse cytoplasmic distribution 
[218]. It is possible that ROQUIN RING-deficient protein complexes are 
packaged into P-bodies that are frequently found at the periphery of stress 
granules [219] and represent specialised sites of mRNA decay [120]. We 
speculate that mRNA degradation, particularly of AU-rich sequences leading to 
release of monomeric adenylate ribonucleotides, may be a factor in AMPK 
hyperactivity in P-bodies. However, it is unknown whether RING-inactivated 
ROQUIN or the AMPK functional complex can localise to P-bodies. 
 
By further analogy to TRAF6 and other T cell RING-classed E3 enzymes such 
as GRAIL and CBL-B that undergo autoubiquitination [220, 221] as well as 
target various T cell signalling molecules for ubiquitination (section 3.1.1.), it is 
likely that ROQUIN post-translationally regulates other proteins via RING-
dependent ubiquitination. Since ROQUIN harbours a proline-rich region, 
associated with facilitating protein-protein interactions by binding SH3 domains 
of partners, further screens for ROQUIN E3 ligase protein targets are 
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warranted. SH3 binding appears to be the mechanism of substrate recognition 
and interaction for the direct ubiquitin-dependent regulation of the PI3K 
regulatory subunit, p85, by E3 ligase CBL-B in T cells. Fang et al. [139] 
demonstrated that in Jurkat cells, ectopic expression of p85 with CBL-B 
constructs lacking the proline-rich region entirely, or in part, caused severe 
impairment of the CBL-B!p85 interaction by immunoprecipitation. Furthermore, 
pull down assays of the CBL-B proline-rich region alone, specifically its carboxy 
terminal sequences, were sufficient for detection of p85 immunoprecipitates, 
and deletion of the p85 SH3 domain prevented CBL-B binding, resulting in 
diminished polyubiquitination of p85. 
 
In summary, we uncovered that the ROQUIN RING domain was essential in 
autoubiquitination coupled to stress granule trafficking of its highly stable 
complex with AMPK!1, which it turn leads to subversion of AMPK signalling. 
ROQUIN was not found to associate with FOXO proteins but loss of ROQUIN 
RING signalling in CD4+ T cells resulted in increased phosphorylation of AMPK 
target residues on ACC and the mTOR component RAPTOR, demonstrating 
enhanced AMPK activity. Because AMPK also directly activates FOXO3a [197], 
it is possible that in the mammalian immune system a 
ROQUIN!AMPK!FOXO3a signalling axis represents a semi-conserved 
remnant of RLE-1!DAF-16 cross-talk observed in early nematode worms. 
Further analysis of AMPK-mediated phosphorylation of FOXO3a in Tringless 
Tfh cells may reconcile the degree of RLE-1!DAF-16 conservation in mammals. 
 87 
chapter five 
5. Linking ROQUIN RING signals to the  
modulation of Tfh cell responses 
 
5.1. Preamble 
Previously, we had shown that the Tfh cell-promoting ROQUIN RING domain 
acts to directly attenuate AMPK activity. ROQUIN binds to the T cell-specific !1 
subunit of AMPK and this stable ROQUIN-AMPK!1 complex is directed into 
transient stress granules via ROQUIN RING-mediated autoubiquitination 
signals. We conclude that this novel mechanism of ! sequestration by ROQUIN 
functions to dissociate the AMPK functional complex since our results showed 
that ROQUIN+ stress granules exclude other core AMPK regulatory ! and ! 
components. We found that in CD4+ T cells and primary MEFs, absence of the 
ROQUIN RING domain results in unrestrained AMPK activity, including AMPK-
directed inhibition of mTOR kinase. 
 
5.1.1. Molecular repression of mTOR by AMPK 
Critical to cell growth and metabolic activity is the evolutionarily conserved 
serine/threonine protein kinase mTOR, which can configure into two distinct 
molecular complexes, RAPTOR-dependent mTOR Complex 1 (mTORC1) or 
RICTOR-dependent Complex 2 (mTORC2). These two mTOR complexes are 
differentially regulated and have distinct cellular binding partners and substrate 
specificities [222]. mTORC1 acts to promote cap-dependent mRNA translation 
by inhibiting 4EBP1 and activating S6K [223-225], thus driving protein 
synthesis, while mTORC2 targets PKC! and F-ACTIN for cytoskeletal 
rearrangement [226], and activates AKT that transduces signals from the PI3K 
pathway [227]. mTORC1 and mTORC2 can overlap in their capacity to sense 
nutrients and amino acid availability. Both mTOR complexes can support T cell 
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growth by driving glucose metabolism albeit via different pathways: mTORC1 
couples expression of HIF1 and c-MYC to mediate glycolysis during CD4+ T cell 
priming [228-230], while mTORC2-dependent control of glycolysis in T cells is 
less defined but possibly linked to its role in activating AKT by direct 
phosphorylation [228, 231-233].  
 
AMPK phosphorylates Ser722 and Ser792 on the RAPTOR component of 
mTORC1 which subsequently prompts 14-3-3 sequestration of phosphorylated 
RAPTOR [212]. Additionally, AMPK activates the mTORC1-inhibitory TSC1-
TSC2 heterodimeric complex by directly phosphorylating its TSC2 (also named 
Tuberin) subunit on Homo sapiens Ser1387 or Mus musculus Ser1366, enhancing 
its activity [234]. Specifically, the TSC1-TSC2 complex facilitates the GTPase 
function of RHEB to hydrolyse GTP, which prevents the mTORC1-activating 
facultative role of RHEB when bound to GTP. Therefore, the mTORC1 pathway 
is a primary target of AMPK, given its dual inhibitory action on RAPTOR directly  
and on the TSC2-RHEB axis. 
 
5.1.2. CD4+ T cell AMPK-mTOR signalling in vivo  
Although the AMPK-mTOR axis is well known to broadly affect cell physiology 
[235], its immunomodulation of peripheral CD4+ T cell responses remains 
unclear. The !1 isoform is the dominant AMPK catalytic subunit in CD4+ T cells, 
whereas AMPK!2 protein does not appear to be expressed in these cells [201]. 
In vitro anti-CD3 and -CD28 stimulation of CD4+ T cells lacking AMPK!1 exhibit 
no phenotypic disruption [236, 237]. However, there are conflicting reports of 
AMPK!1 deficient CD4+ T cells responses in vivo. Mayer et al. [237] 
demonstrated that OTII TCR transgenic AMPK!1 knockout CD4+ T cells 
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proliferate normally when adoptively transferred into C57BL/6 recipients 
injected with OVA peptide in the footpad, and that germline AMPK!1 deficiency 
in C57BL/6 mice does not alter T cell-dependent IgG antibody responses in 
mice immunised with arsonate-KLH. In contrast to these findings, Blagih et al. 
[238] detected a mild but signficant increase in CD4+ T cell IFN! expression in 
mice with a T cell-restricted AMPK!1 deletion. However upon naïve T cell 
colitogenic transfer into Rag1 knockout mice, AMPK!1 deficient IFN!+ Th1 cells 
and IL-7+ Th17 cell counts were profoundly diminished in gut-associated 
lymphoid organs of recipients, abrogating inflammatory bowel disease. In 
another report, MOG peptide immunisation of whole body AMPK!1 knockout 
mice on a C57BL/129 mixed background resulted in a significant exaggeration 
of T cell-mediated autoimmune neuroinflammation [239]. In light of the 
phenotypic variability between these independent studies, it remains unclear 
whether AMPK!1 deficiency confers any change in CD4+ T cell immunity, or 
acts to promote or negatively regulate effector T cell responses in mice.  
 
Loss of AMPK!1 in T cells leads to a 2-fold increase in glycolytic rate and 
augmented mTOR signalling [236], reflective of more ubiquitous findings from 
pioneering and more recent studies of AMPK deficiency or inactivation in 
various tissue types and cell lines. In T cells, hyperactive mTOR can potentiate 
severe CD4+ T cell-dependent autoimmune diseases such as type 1 diabetes 
[240] and systemic lupus erythematosus [241, 242]. mTOR activity is critical for 
the differentiation of effector T cell populations. Delgoffe et al. [243] showed that 
dual loss of mTORC1 and mTORC2 in T cells, by deletion of the core mTOR 
component, can favour Treg cell lineage commitment at the expense of effector 
CD4+ T cell (Th1, Th2 and Th17) responses in vivo after priming of peripheral 
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naïve T cells. Similarly, mouse Treg cells expressing a hypomorphic mTOR 
knock-in allele were significantly expanded upon in vitro stimulation [244]. 
However, in mice with T cell-specific deletions of either RHEB or RICTOR, to 
extinguish mTORC1 or mTORC2 signalling, respectively, the Treg cell 
compartment is largely unperturbed while Th1 and Th17 cell differentiation is 
selectively crippled by mTORC1 deficiency and mTORC2 ablation diminishes 
the formation of Th2 cells [245]. Defective expression of intracellular GATA3 
and an inability for CD4+ T cells to polarise into Th2 cells in vitro due to 
mTORC2 deficiency, were consistent with an earlier report on an independent 
mouse strain harbouring a T cell-specific RICTOR deletion [231]. Despite their 
normal cell frequencies, mTORC1 deleted Treg cells display a reduced 
functional capacity to suppress effector T cell responses, including in vitro T cell 
proliferation and IFN! cytokine production as well as autoreactive and 
autoinflammatory responses in a mouse model of CD4+ T cell-driven colitis 
[228]. Conversely, mTORC2 deleted Treg cells retain immunosuppressive 
functional competence. Collectively, these studies of mice harbouring targeted 
genetic modifications in core mTOR components support a role for mTOR 
orchestrating cell fate decisions between CD4+ effector and regulatory T cells, 
with mTORC1 and mTORC2 exerting distinct influences to promote specific 
effector T cell lineages. 
 
Whether an AMPK-mTOR signalling axis exists in Tfh cell reponses is unknown. 
Delgoffe et al.’s [243] Frap1 knockout CD4+ T cells display reduced expression 
of IL-21 when cultured in vitro. Low expression and secretion of IL-21 was also 
observed in Rapamycin-treated human CD4+ T cells polarised toward the Tfh 
cell lineage ex vivo [246]. And in mice with reduced mTOR, T cell-dependent 
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B cell proliferation, isotype switching, GC formation and antigen-specific 
antibody responses were found to be significantly diminished [244, 247]. 
Recently, Ray et al. [248] investigated the role of mTOR in SMARTA TCR 
transgenic CD4+ T cells following their transfer into OTII TCR transgenic 
recipient mice infected with LCMV. In this system, the proportion of Tfh cells 
differentiated from donor cells doubled by transduced shRNA knockdown of 
mTOR or RAPTOR expression. Intriguingly, a significant increase in the 
percentages of mTOR or RAPTOR knockdown Tfh cells, relative to tranduced 
control Tfh cells, did not coincide with their trending decrease in absolute cell 
numbers and significant reduction in intracellular BCL6 expresson, in addition to 
an undisrupted GC B cell compartment in the same donor-recipient double TCR 
transgenic mice. Therefore, how T cell mTOR acts to control physiolgical Tfh 
cell responses in vivo and their capacity to support GC reactions remains 
unresolved. 
 
This chapter presents two related and overlapping sets of findings. The first part 
explores a link between T cell ROQUIN RING-AMPK signalling and T cell-
dependent B cell responses by determing the in vivo role of mTOR, a bone fide 
AMPK target, in Tfh cells within non-antigen repector transgenic mice. The 
second part of this chapter addresses whether there is functional 
compartmentalisation in the ROQUIN RING and ROQ domains based on the 
novel RING functions characterised in this thesis and the widely-reported RNA 
regulatory activity of the ROQ domain. Determining whether there is functional 
cross-talk between the ROQUIN RING and ROQ domains may serve to clarify 
the mechanism of action of mutant ROQUINM199R expressed in sanroque mice, 
and the nature of the enigmatic sanroque autoimmunity, a spontaneous 
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phenotype not observed in modified mouse strains bearing Rc3h1 loss-of-
function alleles. 
 
5.2. Results 
5.2.1. Tfh cells are crippled in mTOR-defective chino mice 
Our previous studies uncovered evidence of impaired Tfh cell formation, lower 
expression of BCL6 and the mTOR-dependent cytokine IL-21 in Tringless CD4+ 
T cells displaying hyperactive AMPK repression of mTOR signalling (section 
3.2.4. and Figure 4.4.). This led us to speculate that mTOR may be required for 
promoting Tfh cell responses. To test whether mTOR signalling is a factor in 
T cell-dependent B cell responses in a polyclonal T and B cell repertoire, we 
examined a mutant mouse strain named chino, which harbours a hypomorphic 
mutation (chi allele) in the Frap1 gene resulting in an Ile205Ser substitution 
within the HEAT repeat domain of the mTOR protein (Figure 5.1.a), the region 
critical for binding RAPTOR [249]. Unlike the in utero lethality observed in mice 
with complete mTOR deficiency [250, 251], chino is a viable strain that exhibits 
growth retardation, intact thymocyte development and output but reduced 
phosphorylation of rS6 in PMA-treated peripheral CD4+ T cells [135].  
 
We confirmed suboptimal phosphorylation of mTOR targets 4EBP1 and S6K in 
chino peripheral CD4+ T cells in response to physiological TCR activation with 
CD28 costimulation (Figure 5.1.b). This was in contrast to significantly elevated 
FOXP3 expression. Thus, chino mutant T cells represent a mild deficiency in 
mTOR signalling reminiscent of a partial loss-of-function mTOR [244] that 
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Figure 5.1.  Defective mTOR signalling in the chino mouse strain 
(a) chino mutation causes a I
205
S substitution in the mTOR protein. 
(b) Flow cytometric measurements of intracellular phospho-4EBP1 
Thr
37/46
, phospho-S6K Thr
389
, and FOXP3 in CD4
+
 T cells 
stimulated via CD3 and CD28 for 30 min (n = 4–6). MFI, mean 
fluorescence intensity; column, group mean, error bars, SD. (c, d) 
chino mutants were immunised with SRBC and taken down 5 days 
later to measure the proportion of PD-1
high
CXCR5
high
 Tfh cells from 
CD4
+
 T cells (c), and the proportion of GL7
high
FAS
high
 GC B cells 
from B220
+
 B cells (d) in the spleen. Dots, individual mice; 
columns, median. Data are representative of three independent 
experiments. Statistics were calculated by Student’s t-test. 
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exclusively affects extrathymic CD4+ T cell differentiation as seen in Delgoffe et 
al.’s [243] T cell conditional Frap1 knockout mice.  
 
In order to evaluate Tfh cell responses in the presence of mTOR deficiency, we 
immunised chino mice with SRBC and assessed the Tfh and GC responses 5 
days later by flow cytometry. We found that PD-1highCXCR5high Tfh cells were 
severely diminished compared to wild-type controls (Figure 5.1.c). This 
corresponded with a marked reduction in the GC B cell response (Figure 
5.1.d). 
 
In chino mice, defective mTORI205S protein is expressed in all cell lineages. 
Therefore, a smaller Tfh cell popluation upon immunisation of chino mice could 
be induced by T cell-extrinsic signals as opposed to defective mTOR signalling 
within CD4+ T cells. We therefore constructed and immunised 50:50 mixed wild-
type:chino bone marrow chimeras with SRBC to disentangle chino Tfh cells 
from autologous immunoregulation and determine if CD4+ T cell intracellular 
mTOR is required for Tfh cell formation. At d7 post-immunisation, we confirmed 
that the percentages of mTOR mutant PD-1highCXCR5high Tfh cells were 
decreased relative to their competing wild-type counterparts (Figure 5.2.a). This 
was associated with reduced BCL6 expression intrinsic to mTOR mutant CD4+ 
T cells (Figure 5.2.b).  
 
Mixed bone marrow chimeras also revealed that chino CD4+CD44high activated 
T cells and GL7highFAShigh GC B cells were outcompeted by wild-type cells, in 
contrast to Treg cells that gained a competitive advantage by loss of mTOR 
function (Figure 5.2.c). A decrease in the CD4+CD44high pool of effector T cells  
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Figure 5.2.  Requirement of mTOR intracellular activity in GC lymphocytes 
(a-c) Flow cytometric analysis 50:50 mixed donor LY5A wild-type:LY5B chino 
bone marrow chimeras d7 post-SRBC immunization showing the proportion of 
PD-1
high
CXCR5
high
 Tfh cells (a), and expression of intracellular BCL6 (b) from 
the LY5A
+
 and LY5A
!
 CD4
+
B220
!
 T cells. (c) Proportion of CD44
high
 antigen 
experienced T cells, FAS
high
GL7
high
 GC B cells and FOXP3
+
 Treg cells. Linked 
dot symbols, congenic cells from same animal; MFI, mean fluorescence 
intensity. Data are representative of two independent experiments. Statistics 
were calculated by Paired Student’s t-test between congenically marked cells of 
the same animal; n.s., not significant. 
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in parallel to a boost in Treg cells serves as a point of reference for the 
requirement of mTOR in differentially regulating these opposing T cell 
populations in vivo [243]. Likewise, it is known that B cell mTOR signalling is 
necessary for their follicular differentiation into GCs [252]. 
 
Together, our data therefore demonstrate that Tfh cells depend on intact 
intracellular mTOR signalling and that defective mTOR in CD4+ T cells 
throughout Tfh cell formation results in a striking phenotypic resemblance to 
ROQUIN RING-deleted Tfh cell responses. Not only does T cell mTOR act in 
the same polarity as the ROQUIN RING domain during Tfh cell development, 
but since mTOR signalling is a bone fide target of AMPK-directed inhibition in 
CD4+ T cells [236, 253], it is likely that mTOR, at least in part, represents a 
molecular pathway between the ROQUIN–AMPK signalling axis and the control 
of Tfh responses. 
 
5.2.2. mTOR controls the Tfh versus Tfr cell balance 
In experimental mice, treatment of autoimmune arthritis or colitis with the AMPK 
agonist Metformin can significantly reduce numbers of pathogenic IL-17+ Th17 
cells while boosting FOXP3+ Treg cell counts and dampening T cell-mediated 
disease [254, 255]. This is consistent with AMPK negative regulation of mTOR 
and its role in promoting non-follicular effector CD4+ T cells (Th1, Th2 and 
Th17) versus Treg cells in vivo [231, 243, 245]. By extension of this paradigm to 
GC T cells, we sought to test if defective mTOR signalling could cripple Tfh cells 
while leaving intact or boosting FOXP3+ Tfr cells, a distinctly 
immunosuppressive follicular T cell subset (section 1.2.2.) with a yet unclear 
developmental and/or maturation pathway.  
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chino mice were immunised with SRBC and FOXP3! Tfh and FOXP3+ Tfr cells 
from the CD4+PD-1highCXCR5high total pool of splenic Tfh cells were examined 
by flow cytometry at d7 (Figure 5.3.a). Compared to wild-type littermates, 
mTOR deficiency was found to favour a Tfr cell bias over Tfh cells in chino 
mice; the ratio between FOXP3! Tfh and FOXP3+ Tfr cell numbers in the spleen 
was halved (Figure 5.3.b).  
 
To determine if skewed FOXP3! Tfh to FOXP3+ Tfr cell ratios were due to 
defective mTOR signalling in either or both follicular T cell subsets, we injected 
SRBC into chimeric mice reconstituted with a 50:50 mix of wild-type:chino bone 
marrow and analysed follicular T cell responses by flow cytometry. At d7 post-
SBRC immunisation, both populations of chino FOXP3! Tfh cells and chino 
FOXP3+ Tfr cells were severely constrained in the presence of their wild-type 
counterparts (Figures 5.4.a), suggesting that the competitive fitness of both 
FOXP3! Tfh and FOXP3+ Tfr cells within a shared GC T cell niche is in part 
contingent on intact mTOR activity irrespective of extrinsic signals from the GC 
microenvironment.  
 
Upon alternate analysis of these follicular T cells sharing a GC 
microenvironment in chimeric mice, we found a 10.4-fold decrease in the 
frequency of chino FOXP3! Tfh cells compared to wild-type LY5A! FOXP3! Tfh 
cells of control mice (Figure 5.4.b). This was a relatively severe decline in 
contrast to a minor 2.8-fold reduction of chino FOXP3+ Tfr cells when compared 
LY5A! FOXP3+ Tfr cells of control mice. These results show that loss of mTOR 
function in Tfr cells does not lead to their accumulation nor provide a favourable  
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Figure 5.3.  mTOR controls the balance between Tfh and Tfr cells 
(a) Flow cytometry gating strategy to identify FOXP3
–
 Tfh cells and FOXP3
+ 
Tfr 
cells from the PD-1
high
CXCR5
high
 pool of total Tfh cells. (b) The proportion of 
FOXP3
–
 Tfh cells and FOXP3
+ 
Tfr cells in the GC of chino mice and littermates 
(left) and the ratio FOXP3
–
 Tfh to FOXP3
+ 
Tfr cells (right) in mutant chino mice 7 
d post-SRBC immunisation. Data are representative of three independent 
experiments. Statistics were calculated by Student’s t-test after log 
transformation of ratios values. Dots, individual mice; columns, median.  
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Figure 5.4.  mTOR deficiency cripples both Tfh and Tfr cells 
(a) Flow cytometric analysis 50:50 mixed LY5A wild-type:LY5B chino bone 
marrow chimeras at d7 post-SRBC immunisation showing the proportion of 
FOXP3
–
PD-1
high
CXCR5
high
 Tfh cells and FOXP3
+
PD-1
high
CXCR5
high
 Tfr cells 
from congenically-marked CD4
+
B220
–
 T cells. Linked dot symbols, paired data 
from the same animal. Statistics were calculated by Paired Student’s t-test 
between congenically marked cells of the same animal. (b) An alternate 
analysis of LY5A
–
 mTOR defective chino Tfh and Tfr cells competiting with 
LY5A
+
 wild-type Tfh and Tfr cells in a shared GC niche. Representative FACS 
plots (left) and stacked column graph (right) are shown. Each column, individual 
mice. Data are representative of two independent experiments. 
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growth advantage over other resident GC T cells but cripples their competitive 
competency, albeit to a lesser extent than FOXP3! Tfh cells. 
 
Next, we assessed the Tfh:Tfr cell balance in Tringless x Vav:Bcl2 crosses 
(Figure 5.5.a) and in Tringless mice d10 post-LCMV inoculation (Figure 5.5.b). 
In both Tringless experimental groups, a decrease in FOXP3! Tfh:FOXP3+ Tfr 
cell ratios was detected compared to Rc3h1 floxed wild-type littermates. These 
data, alongside our earlier Tringless findings of subdued Tfh cell responses 
associated with loss of AMPK repression in T cells, support a mechanism of 
action for the ROQUIN RING finger in T cells: antagonism of AMPK-directed 
mTOR repression to optimise the balance between Tfh cells and Tfr cells in 
favour of promoting GC reactions. 
 
5.2.3. Genetic complementation of ringless and sanroque mice 
At first inspection, it seems paradoxical that the RING and ROQ domains, two 
adjacent amino terminal regions of ROQUIN, display opposing activities in their 
control of Tfh responses. The RING domain acts to facilitate Tfh cell formation 
while a functional ROQ domain appears necessary in curtailing spontaneous 
Tfh cell accumulation. Dissecting the allelic relationship between rin and san of 
the Rc3h1 locus in mouse lymphocytes could shed some light on this matter. To 
explore this, we performed genetic complementation studies between ringless 
and sanroque mice to generate a Rc3h1rin/san transheterozygous immune 
system (not restricted to T cells) and measured ICOS and Tfh cells, known to 
be repressed by the ROQUIN ROQ domain and this repression perturbed in the 
presence of the san allele.  
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Figure 5.5.  ROQUIN RING loss reduces Tfh:Tfr cell ratios 
(a) Proportion of FOXP3
– 
Tfh cells and FOXP3
+
 Tfr cells from the      
PD-1
high
CXCR5
high 
pool of total Tfh cell cells (left) and ratio of Tfh to Tfr 
cell numbers in Tringless crossed to Vav:Bcl2 transgenic mice. Data are 
representative of two independent experiments. (b) Tringless mice were 
infected with LCMV and spleens analysed by flow cytometry 10 d later 
to measure the proportion of FOXP3
–  
Tfh cells and FOXP3
+
 Tfr cells 
from either total Tfh cell cells or virus-specific GP66-77
+
 Tfh cells (left) 
and ratio of total Tfh to total Tfr cell numbers (right). Statistics were 
calculated by Student’s t-test after log transformation of ratios values. 
Dots, individual mice; columns, median. Data on LCMV infected mice in 
panel b were generated, analysed and kindly provided by Dr. I. Parish 
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In the spleens of Rc3h1rin/san mice, spontaneous accumulation of 
PD-1highCXCR5high Tfh cells was detectable (Figure 5.6.a) alongside an 
autonomous expansion of GC B cells (Figure 5.6.b) at a higher frequency than 
san/+ heterozygotes. Surface ICOS expression on both CD4+CD44low and 
CD4+CD44high T cells was elevated compared to wild-type or rin/+ and san/+ 
heterozygotes but did not equate nor exceed maximal ICOS expression 
observed in san/san homozygotes (Figure 5.6.c). This trend was similarly noted 
in spleen sizes of various Rc3h1 mutant mice (Figure 5.6.d). Altogether, our 
data suggest that adoption of a single copy of the rin allele did not disrupt 
immune homeostasis but compounded with the san allele. rin/san amounted to 
an overall lymphoid profile resembling an intermediate of the sanroque 
heterozygous and homozygous phenotypes.  
 
The above experiment reveals that the rin allele is a hypomorphic allele and 
that there is partial dominance of the san loss-of-function allele over the rin 
allele, which encodes a truncated ROQUIN protein with a functional ROQ 
domain. Notably, since heteroallelic combination of rin and san did not fully 
recapitulate sanroque homozygosity, we conclude that ROQUIN RING loss 
does not represent a complete ROQUIN knockout. This aligns with the 
differences in ICOS expression between CD4+ T cells of Tringless (section 
3.2.3.) and of Bertossi et al.’s [126] T cell-restricted Rc3h1 null mice. But does 
the san-encoded ROQUINM199R protein harbour a functional RING finger?  
 
5.2.4. ROQUIN RING couples stress granules to mTOR repression 
As previously mentioned (sections 4.2. and 4.3.), cellular stress signals are 
tightly linked with the control of AMPK activity, cytoplasmic stress granules, and  
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Figure 5.6.  Spontaneous immune dysregulation of heteroallelic rin/san mice 
(a-d) Proportion of PD-1
high
CXCR5
high
 Tfh cells (a) and GL7
high
FAS
high
 GC         
B cells (b), ICOS surface expression on CD44
low
 and CD44
high
 CD4
+
 T cells (c) 
and harvested whole spleens (d) from progeny of rin/+ and san/+ heterozygous 
crosses. Data are pooled from two independent experiments. Statistics were 
calculated by one-way ANOVA with Bonferroni’s multiple comparisons test after 
log transformation of ratio values, n.s., not significant. Dots, individual mice; 
columns, median. 
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the transient arrest of proliferative growth pathways. This integrated stress 
response network has also been reported to repress mTOR activity by inducing 
the sequestration and inactivation of the RAPTOR component of mTORC1 into 
stress granules [256]. In addition to RAPTOR, stress granule sequestration of 
the core mTOR protein common to both mTORC1 and mTORC2 has also been 
reported [257], suggesting a potentially new mode of mTORC2 regulation. 
mTOR repression by stress granules may be tied to AMPK activity given a 
report by Hofmann et al. [258], demonstrating AMPK inhibition by the 
pyrazolopyrimidine, Compound C, abrogated the formation of cytoplasmic 
stress granules in COS7 cells in response to cold shock. In light of these 
independent findings that point to a mechanism for AMPK-dependent stress 
granule induction linked to subversion of mTOR signalling components, we 
sought to obtain further evidence of functional differences between AMPK 
activity between RING and ROQ-defective ROQUIN. 
 
We first confirmed a need for AMPK in arsenite-induced stress granule 
formation in primary MEFs treated with the AMPK inhibitor, Compound C 
(Figure 5.7.a). We then set out to compare stress granule formation and 
disassembly in MEFs expressing RING or ROQ-defective ROQUIN. In ringless 
MEFs exposed to arsenite, stress granule counts per cell were not altered 
(Figure 5.7.b), nor was the size of stress granules determined by area (Figure 
5.7.c) and maximal ferret (Figure 5.7.d) under immunofluorescence 
microscopy. Upon stress recovery of cells in arsenite-free complete media, we 
detected prolonged stress granule disassembly in ROQUIN RING deleted 
MEFs (Figures 5.8.a and 5.8.b). This was also observed in C57BL/6 MEFs 
treated with the AMPK pharmacological activator 5-aminoimidazole-4- 
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Figure 5.7.  Induction of stress granules 
(a) Fluorescence microscopic analysis of primary MEFs showing the 
proportion of cells with cytoplasmic eIF3
+
 stress granules (SG) 
immediately after cellular exposure to 1 mM arsenite (AS) for 30 min 
with or without 50 µM Compound C (CompC). Statistics were 
calculated by Student’s t-test, n = 10, with each n replicate 
representing a single field of view displaying 1–7 adherent cells. 
Columns, mean; error bars, SD. (b-d) Analysis of SG induction in 
primary MEFs by fluorescence microscopy after 1 h of 1 mM arsenite 
treatment to assess counts of eIF3
+
 granules per cell (b), and size of 
individual eIF3
+
 granules in freshly arsenite-stressed primary MEFs 
based on area (c) and maximum feret (d). Statistics were calculated 
by Student’s t-test. Dot symbols, individual cell. All data included 
(panels a-d) were produced in collaboration with Dr. V. 
Athanasopoulos from at least three independent experiments. 
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Figure 5.8.  Extension of stress granule dissolution 
(a) Proportion of wild-type and ringless MEFs recovering in complete DMEM 
media and exhibiting cytoplasmic eIF3
+
 stress granules (SG) after 1 hr of 1 mM 
arsenite treatment. Columns, mean; error bars, SD. (b) Representative 
micrographs displaying recovered MEFs at 3 h post-arsenite stress. Scale bar, 
50 µm. Data are representative of three independent double blind experiments. 
(c) Proportion of MEFs presenting with eIF3
+
 stress granules while recovering 
with or without 2 mM AICAR in complete DMEM after 1 hr of 1 mM AS 
treatment. Data are representative of three independent double blind 
experiments.  (d) Proportion of MEFs with eIF3
+
 stress granules after 1 hr of 1 
mM arsenite treatment comparing wild-type and sanroque MEFs recovering in 
complete DMEM. Error bars, SD. Statistics were calculated by Student’s t-test, 
n.s., not significant. Data are representative of two independent experiments (n 
>30 per time point; each n replicate represents a single field of view displaying 
1–6 adherent cells). (e) Colocalisation of RAPTOR and eIF3
+
 stress granules in       
1 mM arsenite-stressed MEFs. Data are representative of three independent 
experiments. All data included (panels a-e) were produced in joint collaboration 
with Dr. V. Athanasopoulos.  
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carboxamide ribonucleotide (AICAR) (Figure 5.8.c). However, in post-arsenite 
recovering sanroque MEFs (Figure 5.8.d), stress granule dissolution was 
comparable to wild-type cells, thus implicating an intact ROQUIN RING domain 
in the prevention of prolonged stress granule stability.  
 
These data align with the emerging role for AMPK and stress granules in the 
regulation of mTOR kinase. AMPK may therefore act as a master negative 
regulator of mTOR kinase activity by: (i) promoting the formation and longevity 
of stress granules as we had demonstrated in MEFs, and (ii) its classical 
mechanism of action, directly phosphorylating RAPTOR and TSC2. In both wild-
type and ringless MEFs, we confirmed normal RAPTOR localisation to arsenite-
induced eIF3+ stress granules (Figure 5.8.e). Taken together, our data suggests 
that impaired mTOR signalling in ROQUIN RING deficient cells displaying 
hyperactive AMPK activity may be a result of AMPK-mediated stress granule 
sequestration of mTOR proteins. On the other hand, aberrant mTOR 
deactivation by AMPK signalling and stress granules is an unlikely 
consequence of ROQUIN ROQ dysfunction given no significant changes in 
stress granule kinetics in sanroque cells in response to arsenite-induced stress. 
 
5.2.5. A role for mTOR in pathogenic sanroque Tfh cells 
Autoantibody responses and lymphoid cell accumulation in sanroque mice are 
potentiated by unrestrained IFN! and ICOS overexpression [118, 125]. 
However, whether the Tfh versus Tfr cell balance and/or mTOR activity is a 
factor in the autonomous expansion of Tfh cells in sanroque mice remains 
unknown. Since we had established lower Tfh to Tfr cell ratios as a direct 
consequence of reduced T cell mTOR signalling, we looked to sanroque mice to 
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determine if a Tfh:Tfr cell imbalance was detectable within spontaneous 
follicular T cell responses. Indeed, we observed an significant increase in 
FOXP3! Tfh:FOXP3+ Tfr cell ratios in sanroque spleens (Figures 5.9.a and 
5.9.b), a notable inverse phenotype to ROQUIN RING deleted T cells and chino 
mice. Moreover, ICOS was over-expressed in both FOXP3! and FOXP3+ 
follicular T cell subsets of resting sanroque mice (Figure 5.9.c), suggestive of 
dysfunctional ROQUINM199R acting in both cell populations. 
 
Finally, to test if mTOR activity is required for the aberrant expansion of Tfh 
cells in sanroque mice, we administered the pharmacological mTOR inhibitor 
Rapamycin into sanroque mice over 4 weeks and analysed Tfh cells and GC 
reactions in spleens by flow cytometry. We found complete normalisation of the 
Tfh cell (Figure 5.10.a) and GC B cell compartments (Figure 5.10.b) but Treg 
cells appeared unchanged (Figure 5.10.c). Together, these results support an 
important role for mTOR in potentiating aberrant Tfh cell responses that can 
drive pathogenic GC reactions. 
 
5.3. Discussion 
In the first part of this chapter, we deciphered whether the highly conserved 
mTOR kinase acts in a similar manner to the ROQUIN RING activity by 
promoting Tfh cell formation. We tested whether ROQUIN RING is coupled to 
AMPK-mTOR in Tfh cells, given that multiple studies of CD4+ T cell responses 
in AMPK!1 deficient mice have yielded varying results [237-239]. In vivo 
models for constitutively-active T cell AMPK!1 have not been documented, but 
we speculate could parallel the AMPK!1 constitutive activity we have previously 
observed in Tringless T cells. 
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Figure 5.9.  Follicular T cell subsets in sanroque mice 
(a) Flow cytometric analysis of resting sanroque mutant mice showing the 
proportion of FOXP3
–
 Tfh cells and FOXP3
+
 Tfr cells within the total              
PD-1
high
CXC5
high
 Tfh population (a), ratio of FOXP3
–
 Tfh to FOXP3
+
 Tfr cell 
numvers (b), ICOS surface expression on FOXP3
–
 Tfh and FOXP3
+
 Tfr cells in 
sanroque mice. Group bar, median; dot symbols, individual mice; MFI, mean 
fluorescence intensity. Statistics were calculated by Student’s t-test. Ratio 
values in panel b were statistically analyzed after log transformation. Data are 
representative of two independent experiments. 
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Figure 5.10.  Rapamycin treatment of sanroque mice 
(a-c) Flow cytometric analysis of sanroque mice after 4 w treatment with 
Rapamycin (Rapa) to measure the proportion of ICOS
high
CXCR5
high
 Tfh cells 
(a), FOXP3
+
 Treg cells (b), GL7
high
FAS
high
 GC B cells (c). Group bar, median; 
each dot symbol, individual mice. Statistics were calculated by one-way ANOVA 
with Bonferroni correction. All data presented were generated, analysed and 
kindly donated by Dr. M. Linterman from one experiment. 
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Metformin is widely used as a hypoglycemic drug known to activate intracellular 
AMPK activity [259, 260] via phosphorylative induction of AMPK!1 [261, 262] 
and suppression of AMPK inhibitory signals such as cyclic AMP and Protein 
kinase A (PKA) [263]. In a recent report, Metformin treatment of experimental 
autoimmune encephalomyelitis in mice was shown to mitigate pathogenic Th17 
responses and promote Treg cell expansion via repression of CD4+ T cell 
mTOR signalling [264]. In vitro mTOR inhibition by Metformin has also been 
observed in multiple cell lines of T cell acute lymphoblastic leukemia, including 
BE-13, CEM-R, RPMI-8402 and Jurkat cells [265]. Our findings identify a T cell-
instrinsic requirement for mTOR signalling in polyclonal follicular T cell 
responses to immunisation. We found that mTOR acts within CD4+ T cells to 
faciliate expression of BCL6 and differentiation of PD-1highCXCR5high Tfh cells, 
inclusive of FOXP3! Tfh cells and FOXP3+ Tfr cells. However, amongst wild-
type follicular T cells in a competitive setting, the frequency of mTOR-defective 
FOXP3! Tfh cells was greatly reduced relative to a much smaller decline in 
mTOR-defective FOXP3+ Tfr cells. Increased resistance in Tfr cells to the 
deleterious effects of mTOR deficiency could explain why hypomorphic mTOR 
mutant mice generate a lower ratio of FOXP3! Tfh cells to FOXP3+ Tfr cells, 
which we here and others before [109, 266] have shown to be a faithful positive 
reporter for the magnitude of GC reactions. 
 
We propose two models for the differential control of FOXP3! Tfh cells and 
FOXP3+ Tfr cells by intracellular mTOR signalling upon T cell-dependent 
induction of GCs. It is likely that both pathways are synergistic and non-mutually 
exclusive: 
 112 
(i) mTOR may be regulated at the initial priming of peripheral naïve CD4+ T cells 
by dendritic cells. It  has recently been revealed that activated CD4+ T cells can 
give rise to both FOXP3! Tfh cells [267] and FOXP3+ Tfr cells [71]. Given that 
PD-1 on CD4+ T cells is known to transduce inhibitory intracellular signals to 
mTOR [268] and is preferrentially highly expressed on Tfr cells [109], we 
speculate that during de novo peripheral Tfr cell differentiation, early T cell PD-1 
ligation by dendritic cell-derived PD-L1 [71] and continued PD-1 ligation, by 
cognate B cells, dampen tonic mTOR signals in GC Tfr cells. 
(ii) FOXP3! Tfh cells and tTreg-derived FOXP3+ Tfr cells [66, 69], despite their 
differentiation from distinct precursors, may be unequally dependent on mTOR 
activity. This is supported by our results and independent studies of chino 
mutant mice [135] and Delgoffe et al.’s [243] T cell-restricted Frap1 knockout 
mice, showing largely unperturbed thymic development of T cells but severely 
crippled peripheral CD4+ T cell effector differentiation.  
 
In the second part of this chapter, we examined the functional relationship 
between the RING and ROQ domain of ROQUIN in vitro and in vivo. We found 
incomplete dominance of the Rc3h1 san allele over the rin allele by heteroallelic 
combination. The phenotype of rin/san GC T and B cells at homeostasis did not 
recapitulate that of san/+ heterozygotes or san/san homozygous mice but was 
an intermediate between these two sample groups. The rin/san phenotype was 
not consistent with the Mendelian dominance of the individual rin and san 
alleles over wild-type traits. An apparent absence of any developmental or 
immune defects in rin/+ adult mice and in Trin/+ (Rc3h1lox/+ x Lck:Cre) T cells 
(section 3.2.3. and J. Fitch 2009, Honours Thesis), is a classical demonstration 
of recessive traits that only manifest in homozygousity.  
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Knowing that both rin/+  and Trin/+ genotypes specifically encode for ROQUIN 
RING haploinsufficiency, rin/san hybrid mice should not phenotypically manifest 
low dose RING activity as the RING domain is intact in the san allele. 
Conversely, san/+ heterozygotes display spontaneous Tfh accumulation and 
GC reactions, albeit with inferior magnitude and kinetics as san/san mice [45]. 
Thus would signify that a rin encoded active ROQ domain would not be 
sufficient to overcome the incomplete dominance of san nor its associated 
dose-dependent disruption of immune homeostasis in rin/san 
transheterozygotes. Taken together, the rin/san and san/+ genotypes should 
therefore express equivalent traits on a theoretical basis. Yet this does not 
reconcile with the data. It could suggest epigenetic transvection between the 
allelic homologues of rin and san. For instance, Histone deacetylase 9 (HDAC9) 
has been implicated in Rc3h1 regulation with Yan et al. [269] finding that 
HDAC9 knockout CD4+ T cells display a two-fold increase in Rc3h1 gene 
expression. Also, Leppeck et al. [116] had performed a bioinformatic screen of 
mRNA squences in 46 vertebrate species and identified a potential ROQUIN 
ROQ target CDE conserved within its own Rc3h1 mRNA 3’ untranslated region, 
implying a mode of autoregulation at the post-transcriptional level. It is possible 
that in rin/san mice, rin transcription and/or mRNA is preferentially repressed 
due to selective pressures that favour the advantageous (aberrant) growth 
signals afforded by san. This would result in near complete allelic dominance for 
san while rin is silenced to resemble a null-like allele. Another explanation for 
the unique rin/san phenotype could be some post-translational cross-talk 
between the RING and ROQ domains of ROQUIN. A cis-acting RING-ROQ 
regulatory loop within the ROQUIN protein would unlikely reflect the allelic 
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interactions between rin and san, thus pointing to either: (i) trans-regulation and 
interaction between two different ROQUIN mutant proteins in a putative 
complex. Such is a similar case for the stress granule-localising RING-classed 
E3 ligase TRAF2 [217], which forms a trimer [270, 271]; or (ii) indirect signalling 
between the the ROQUIN RING and ROQ domains, for instance, shared distal 
control of components of the PI3K-AKT-mTOR pathway ubiquitous in all 
immune cells. 
 
We discovered that the ROQUIN RING domain is important in coordinating the 
dispersal of cytoplasmic stress granules. This is notably a polar effect of AMPK 
activity in promoting stress granule formation [258] and persistence, and thus 
consistent with our previous findings of ROQUIN RING-mediated attenuation of 
AMPK (sections 4.2.2 and 4.2.3). Given our earlier demonstration of AMPK!1 
sequestration into stress granules, future analyses may be required to 
understand the kinetics of a potential feedback loop between AMPK signalling 
and stress granule responses. Such a mechanism has similarly been reported 
with the pro-apoptotic kinase ROCK1, which is critical for heat shock-induction 
of FRMP+ and TIA-1+ stress granules yet is subsequently sequestered into and 
inactivated by them [216]. We confirmed that the ROQUINM199R protein 
expressed in sanroque cells retains its RING domain function based on 
comparable rates of stress granule dissolution between sanroque MEF cells 
and wild-type MEFs while a unique and significant delay in stress granule 
recovery was observed in ringless MEFs expressing RING-deleted ROQUIN. It 
is unlikely that a mutated ROQ domain in ROQUINM199R acts dominantly over a 
functionally adjacent RING domain in facilitating stress granule dispersal as no 
advantageous acceleration in recovery rates was observed in sanroque MEFs. 
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Moreover, previous findings by Dr. V. Athanasopoulos highlight that the 
ROQUINM199R protein retains its capacity to coalesce with stress granules [114], 
which we have now confirmed is a trait attributed to RING functionality based 
on deletion or mutational disruption of the ROQUIN RING domain (Figure 4.6.).  
 
 
We identifed an immunological role for mTOR in mediating aberrant Tfh cell 
accumulation in sanroque mice. Treatment of sanroque mice with the mTOR 
inhibitor Rapamycin over 10 weeks resulted in complete amelioration of 
aberrant Tfh and GC B cell responses, however, as we had shown with Treg 
cells intrinsically resistant to mTOR deficiency in 50:50 chino:wild-type mixed 
bone marrow chimeras, sanroque Treg cells were refractory to the suppresive 
effects of Rapamycin. The drastic rescue of sanroque Tfh cells by Rapamycin 
treatment could signify a central role for mTOR in ROQUINM199R RING and 
ROQ domain functional coupling. Given its active state in sanroque cells, the 
ROQUINM199R RING domain and its repression of AMPK could be acting to 
amplify mTOR kinase growth signals, particularly in driving cap-dependent 
translation of ROQUIN target transcripts like Icos, Il6 and Ox40 mRNA that are 
autonomously over-expressed on account of defective ROQ activity. Excessive 
production of these effector proteins would create an immune environment 
conducive to spontaneous and unrestrained Tfh cell-GC reactions.  
 
It is important to note that the sanroque mutation encodes a pathological variant 
of ROQUIN, and thus, in a physiological wild-type setting, mTOR may be acting 
as a regulatory link between RING and ROQ signalling. Specifically, we 
speculate that ROQ-mediated destabilisation of mRNA targets acts to limit input 
to mTOR-dependent protein synthesis downstream of the RING-AMPK axis. 
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This putative RING-ROQ functional coupling is unlikely to be a closed circuit 
and may involve, or be integrated into, other forms of ROQUIN autoregulation.  
 
As yet, there are few known post-translational regulators of ROQUIN and even 
fewer targets of ROQUIN’s E3 ligase activity. Determining whether ROQUIN 
RING signalling during Tfh cell differentiation is modulated by ROQ would 
require further investigation. Additionally, in our Rapamycin experiments on 
sanroque mice, the relative effects of pharmacological mTOR inhibition in Tfh 
cells and/or GC B cells cannot be separated as these GC lymphocytes are 
known to be co-dependent [4]. Although it has previously been shown that Tfh 
cell accumulation in sanroque mice is T cell autonomous, whereas most of the 
GC B cell accumulation is driven by Tfh cell hyperactivity [42, 45], clarification of 
the direct action of Rapamycin in sanroque Tfh cells is warranted. This may be 
achieved without the use of Rapamycin and by genetic complementation of the 
sanroque and chino alleles in competitive bone marrow chimeras reconstituted 
with a 50:50 mixture of san/san x chi/chi:wild-type haemopoietic cells. Possibly 
one other approach could be to monitor spontaneous Tfh cell differentiation of 
donor sanroque x chino CD4+ T cells following their transfer into wild-type 
recipients as it had similarly been done with sanroque T cell transfers [42]. 
 
In summary, we identified a signficant functional distinction of the ROQUIN 
RING finger against the well-characterised ROQ domain. The RING domain 
acts in the same polarity as mTOR to facilitate follicular T cell formation and 
promoting a larger Tfh cell poportion over Tfr cells to maximise GC responses. 
This highlights a pivotal role for ROQUIN in fine-tuning the magnitude of Tfh cell 
responses during T cell-dependent antibody responses. Our results lend 
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support to an active RING domain significantly contributing to the abnormal Tfh-
GC reactions in sanroque mice. This aligns with our initial hypothesis of a 
cross-talk between the ROQUIN RING finger and a defective ROQ domain in 
pathogenic Tfh cell responses (section 1.5.iii). However, additional studies 
would allow definitive resolution of whether the requirement for mTOR activity in 
sanroque Tfh cells is a direct result of intact ROQUINM199R RING-AMPK-mTOR 
signalling acting synergystically with loss of ROQ-mediated mRNA regulatory 
function. 
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chapter six 
6. Final perspectives 
ROQUIN is classically known as a repressor of Tfh cell responses. Loss of its 
RNA regulatory activity attributed to its ROQ and C3H1 domains, causes 
spontaneous T cell activation leading to the pathogenic accumulation of Tfh 
cells, as seen in sanroque mice [45]. In Chapter 3 of this thesis, it was revealed 
that an intact ROQUIN RING domain in T cells was necessary to facilitate Tfh 
cell differentiation, which was paradoxical to the established role of ROQUIN in 
Tfh cell differentiation. Additionally, it was determined that homozygous 
ROQUIN RING deletion in mice resulted in perinatal lethality, and ROQUIN 
RING deficiency in T cells did not cause spontaneous T cell hyperactivity. These 
observations denoted a close phenotypic alignment to Rc3h1 null mice reported 
by Bertossi et al. [126].  
 
In Chapter 4, AMPK was identified as a direct ROQUIN RING signalling target 
in mouse T cells. Loss of ROQUIN RING resulted in hyperactive AMPK and 
deregulation of AMPK-mediated inhibition of mTOR kinase. Intact mTOR 
signalling was found to be important for Tfh cell responses in Chapter 5, thus 
lending support for a ROQUIN-AMPK-mTOR signalling axis in Tfh cell 
responses. Surprisingly, absence of ROQUIN RING or mTOR signalling 
favoured an increase in the frequency of GC-suppressive Tfr cells over B cell-
helping FOXP3! Tfh cells.  
 
Work presented in this thesis adds a completely novel dimension of 
understanding to the function of ROQUIN in follicular T cell responses, and 
sheds some new light on how distinct ROQUIN domains allow for a bimodular 
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mechanism of action important in fine-tuning the magnitude of T cell dependent 
antibody responses (Figure 6.1.) towards infectious agents or against self-
antigens, as seen in sanroque mice. 
 
6.1. ROQUIN signalling in Tfh cells 
Few signalling pathways have been identified to be unique solely to Tfh cell 
development. Rc3h1 is a bone fide transcriptional target of the Tfh-polarising 
nuclear factor STAT3 [272, 273] which can be induced downstream of IL-21 and 
IL-6 surface receptors on CD4+ T cells. However, ROQUIN gene expression is 
not found exclusive to CD4+ T cells but is ubiquitiously expressed in all cell 
lineages including all CD4+ T cell helper and regulatory subsets [45]. So why 
does ROQUIN RING signalling exclusively control Tfh cell formation in vivo and 
leave other effector T cell lineages relatively unaffected? 
 
The ROQUIN RING domain was found to be important for attenuating AMPK 
activity and controlling the longevity of cytoplasmic stress granules, both of 
which represent important cellular stress responses triggered by TCR induction. 
Specifically, phosphorylative activation of AMPK by CaMKK occurs downstream 
of a TCR-mediated calcium influx [201], and stress granule formation is induced 
during CD4+ T cell priming driven by yet unclear TCR signalling molecules 
[123]. It is possible that ROQUIN RING-dependent intracellular stress 
responses may be coupled to the specific TCR signal strength of Tfh-lineage 
restricted cells. In TCR transgenic mice as well as in mice with a polyclonal 
T cell repertoire, T cell clones expressing TCRs with the highest affinity for 
antigen that effectively enable prolonged TCR:peptide-MHCII interactions 
differentiate into Tfh more efficiently than non-Tfh CD4+ T cells [274, 275].  
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Figure 6.1.  Molecular mechanism of ROQUIN during Tfh cell responses 
Results from chapters 3 to 5 reveal that ROQUIN is not solely a post-transcriptional 
silencer of Tfh cell differentiation. As an integral component of the NF!B and PI3K 
signalling networks, ROQUIN acts to promote Tfh formation (green) or repress signals 
required for Tfh cell differentiation (red). Upstream signals that control the molecular 
activity of ROQUIN in mRNP granules, as a mediator of RNA decay or post-
translational antagonist of AMPK, are unclear. 
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Results from chapters 3 to 5 reveal that ROQUIN is not solely a post-transcriptional silencer of Tfh 
cell differentiation. As an integral component of the NF#B and PI3K signalling networks, ROQUIN 
can act to promote Tfh formation (green) or repress signals required for Tfh cell differentiation (red). 
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The metabolic demands specific to Tfh cells may also be associated with 
ROQUIN RING-AMPK signalling given the vast influence that AMPK exherts on 
nutrient utilisation pathways. Cellular adenosine metabolism has previously 
been linked to T-dependent antibody responses in mice with the observation 
that antigen-specific Tfh cells displayed constitutively high surface expression of 
CD73, an ecto-enzyme that catabolizes extracellular AMP into adenosine [276]. 
However, Conter et al. [277] noted that in CD73 knockout mice, GC reactions 
were only modestly elevated during a primary response to NP-CGG 
immunisation.  It is therefore possible that Tfh cells utilise a purinergic autocrine 
signalling pathway that has been suggested in Treg cells [278, 279]. In this 
pathway, CD73-generated adenosine external to Tfh cells is imported through 
nucleoside transporters for reversion back into cytoplasmic AMP by adenosine 
kinase. Cytoplasmic AMP may then trigger ROQUIN RING-regulated activation 
of AMPK. Although deregulation of these signals can severely compromise T-
dependent B cell responses, their abrogation does not inversely equate to 
aberrant GC expansion.  
 
Ray et al. [248] found that Tfh cells uniquely display low glycolytic rates 
compared to Th1 cells in an acute antiviral response in mice. This is consistent 
witht the anti-glycolytic activity of the Tfh cell-determinant nuclear factor BCL6 
[280] and AMPK activation in glucose deprived cells [234]. AMPK plays an 
important role in balancing intracellular glucose breakdown under certain 
conditions, either by direct phosphorylative induction of 6-Phosphofructo-2-
kinase (PFK-2) integral to driving glycolysis [205, 281] or by deactivating the 
mTOR kinase pathway (section 5.1.), which promotes HIF1 and c-MYC-
dependent glycolysis in T cells [282, 283]. At first glance, it may seem 
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conflicting that ROQUIN RING deficiency results in unrestrained AMPK leading 
to crippled mTOR signalling and BCL6 expression, and fewer Tfh cells. The role 
of BCL6 to transcriptionally repress glycolysis genes does not appear to 
reconcile with mTOR activity, which drives glycolysis, promotes BCL6 
expression and facilitates optimal Tfh cell differentiation. However, intact 
ROQUIN RING signalling may be advantageous, if not critical in Tfh responses, 
possibly acting to establish a maximal threshold of AMPK activity that is key to 
maintaining narrow Tfh cell numbers for effective GC clonal selection while 
allowing ample, but not excessive, Tfh support to GCs. This underlies the basis 
for why Tfh cell numbers are so tightly contained throughout a GC response, 
acting as a critical limiting factor for controlling the magnitude and clonal 
diversity of GC reactions [3, 177]. 
 
Considering its plethora of cellular phosphorylation targets, it is also possible 
that the ROQUIN-AMPK axis can transduce Tfh cell-modulating signals 
independent of mTOR. Therefore, the Tringless phenotype would not be 
reflective of all mTOR deficient T cell responses. Indeed, AMPK has been 
shown to induce Bcl6 expression by repressing the transcriptional silencer 
PARP-1 in the human umbilical vein endothelial cell (HUVEC) line, and in 
mouse fibroblasts and aortic tissues [284]. However, this axis stands in contrast 
to the low BCL6 expression in Tringless T cells and the role of PARP-1 in 
follicular T cells is unclear. PARP-1 knockout CD4+ T cells have been shown to 
undergo exaggerated extrathymic Treg differentiation from naïve cells [285]. 
This could possibly reflect increased formation of antigen-specific 
FOXP3+BCL6+ Tfr cells during T cell-dependent B cell resposnes, as seen in 
immunised Tringless mice. 
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Future studies are required to dissect the mechanisms by which ROQUIN RING 
signals target Tfh cell differentiation under various immunisation regimes. 
Additionally, the use of in vivo mouse models specilised for non-Tfh cell studies, 
such as T cell transfers into Rag1 knockout recipients for the analysis of Th17 
cell-mediated colitis, could provide better resolution to the role of ROQUIN 
RING signalling in T cell effector responses in vivo. 
 
6.2. ROQUIN and RNA-regulating analogues  
ROQUIN displays significant overlapping mRNA regulatory functions with its 
mammalian paralogue, ROQUIN2, as well as the ribonuclease REGNASE-1 
[110, 117, 119, 203]. However, ROQUIN2 RING deficient or complete null 
homozygous mice present no obvious disruption to T cell homeostasis [117, 
119], and the role of REGNASE-1 in Tfh cell differentiation has yet to be 
investigated. Although complete T cell double deletion of ROQUIN and 
ROQUIN2 in mice leads to significantly increased T cell ICOS expression and 
spontaneous Tfh cell accumulation and GC reactions, these same mice do not 
generate autoantibodies and show abnormal demarcation of follicular T, B and 
dendritic cell zones in spleens [119], representing a similar but not a complete 
reproduction of the sanroque phenotype. Genetic dominance of ROQUIN over 
ROQUIN2, and their shared functions in immunity cannot therefore entirely 
explain the autoimmune disorder in the sanroque mouse strain. Besides the 
compounding effects of ROQUIN in myeloid cells [41, 45, 116]  and possibly in 
B cells [171], it is possible that intact RING signalling in sanroque mice 
contributes to the discrepancies observed. Is the absence of ROQUIN RING 
signals a factor in maintaining immunological tolerance in double ROQUIN and 
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ROQUIN2 deleted mice? Would reintroduction or specific rescue of ROQUIN 
RING signalling in the absence of both Rc3h paralogues be sufficient to drive 
spontaneous T cell autoreactivity? Involvement of the ROQUIN RING finger and 
its putative interactions with functional ROQUIN analogues may provide further 
clues as to how a single M199R substitution event in sanroque mice can cause 
robust T cell-dependent systemic autoimmunity. 
 
Based on their structural similarities and colocalisation in cytoplasmic mRNP 
granules, it is possible that ROQUIN and ROQUIN2 also share post-
translational targets for RING-mediated ubiquitination, as is the case for their 
CDE-containing mRNA targets. However, unlike the ROQUIN RING domain, 
loss of ROQUIN2 RING activity offers little physiological and immunological 
significance at first glance since germline ROQUIN2 RING deleted mice display 
almost no developmental phenotype nor perturbations in immune homeostasis 
[117]. 
 
Cheung et al. [286] identified O-linked N-acetylglucosamine transferase (OGT) 
as a direct ROQUIN2 protein binding partner in a yeast two-hybrid screen of a 
human fetal brain cDNA library. The OGT enzyme catalyses the attachment of 
N-acetylglucosamine monosaccharide moieties  to serine or throenine residues 
of intracellular proteins in response to various cellular stimuli. Interestingly, 
knockdown of OGT in Jurkat  cells with small interferring RNA results in 
significant inhibition of T cell activation [287], and mice harbouring a T cell-
specific hypomorphic mutation in the X-linked Ogt gene demonstrate severe 
CD4+ and CD8+ T cell lymphopenia in spleens, primarily due to an increased 
susceptibility to apoptosis [288]. This finding is consistent with the proteolytic 
tagging of ASK1 by direct ROQUIN2 RING-mediated ubiquitination to 
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coordinate the cell death program in response to stress [132], and with our 
identification of a ROQUIN-AMPK signalling axis linked to stress signalling. 
Leppeck et al. [116] also revealed that ROQUIN could bind to ROQUIN2. This 
may suggest possible heterodimeric complex formation with these paralogues, 
which would substantiate their shared molecular targets. 
 
6.3. The balance between FOXP3! Tfh versus FOXP3+ Tfr cells 
It is increasingly becoming clear that the balance between Tfh and Tfr cells can 
influence the magnitude of GC reactions with emerging extracellular stimuli 
revealing how the preferential abundance of Tfh cells or Tfr cells in GCs can be 
orchestrated. Ding et al. [266] demonstrated the capacity for IL-21 cytokine 
signalling to selectively promote FOXP3! Tfh cells while limiting Tfr cell 
immunosuppressive functions to enhance pathogenic GC reactions in the BXD2 
autoimmune mouse strain. Additionally, the T cell inhibitory receptor PD-1 has 
also been implicated in in follicular T cell responses by predominantly acting on 
Tfr cells, however, it remains debatable whether T cell expressed PD-1 inhibits 
or supports Tfr cell formation during a GC response. In PD-1 deleted mice 7d 
post-immunisation with MOG in CFA, both the frequency and total cell numbers 
of FOXP3+ Treg cell-derived Tfr cells, significantly increased in peripheral lymph 
nodes, which resulted in enhanced suppression of primary T cell-dependent 
antibody responses [109]. These results are in contrast to a recent mouse study 
[71] where PD-1!PD-L1 blockade caused a reduction in antigen-specific Tfr 
cells arising de novo from naïve CD4+ T cells transferred into immunised 
recipients.  
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The ROQUIN-AMPK-mTOR intracellular signalling axis identified in this thesis 
may be integral in transducing environmental stimuli, such as those initiated by 
T cell surface receptors, to control the mutual antagonism between Tfh and Tfr 
cells. Indeed, CD4+ T cell PD-1 receptor activation can couple intracellular 
mTOR signals [268]. The size of the GC T cell niche, antigen abundance or the 
dynamic cross-talk between GC T and B lymphocytes could all contribute as 
extrinsic influences to set a conditional bias that favours either Tfh cell 
responses or Tfr cell immunosuppression. 
 
GC reactions are highly dynamic with various signals being exchanged between 
T cells and other GC leukocytes at distinct time points during a primary 
response to T-dependent antigen (section 1.1.1.). Our results demonstrated an 
altered ratio of Tfh to Tfr cells at d7 post-SRBC immunization and at d10 post-
LCMV infection. This could be a direct result of disrupted GC kinetics in mTOR 
mutant and Tringless mice. In a time course study of GCs using OVA-Alum 
immunised mice, Wollenberg et al. [70] detected maximal FOXP3! Tfh cell 
counts during GC initiation, whereas GC abundance of FOXP3+ Tfr cells peaked 
in the later stages of the primary response, as the total GC volume diminished 
at d12 post-immunisation. A similar approach would be required to specifically 
examine the influence of ROQUIN-AMPK-mTOR signalling on Tfh and Tfr cell 
kinetics in vivo. 
 
The findings in this thesis, which highlight a need for mTOR activity in 
maintaining a balance between Tfh and Tfr cells, adds some depth and possible 
explanation to Ray et al.’s [248] investigation of mTOR function in TCR 
transgenic Tfh cells, which did not take into account the influence of follicular 
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T cell subsets. Unlike this earlier study, we did not observe increased 
percentages of mTOR insufficient Tfh cells. Given the effects of TCR affinity on 
selective Tfh cell differentiation (section 6.1.), and the unclear relationship 
between TCR signal strength and Tfr cell development and/or function, the 
discrepancies in our findings could be explained by the strict use of TCR 
transgenic mice in the abovementioned report in contrast to our analysis of 
polyclonal T cell physiology in chino mice. 
 
6.4. Implications for biomedical translation 
Tfh cells are important for maintaining peripheral tolerance. There is much 
experimental evidence from multiple mouse models [42, 45, 125, 174, 175] 
highlighting the pathogenic potential of unstable Tfh cells in driving systemic 
autoimmunity and a requirement to attenuate Tfh cell signals in an autoimmune 
setting. The involvement of Tfh cells in human autoimmune disease is less 
definitive and more correlative owing to the infeasibility of surgical access to 
lymphoid organs for analysis and in vivo experimentation before and after Tfh 
cell manipulation. Nonetheless, the frequency of CD4+ Tfh-like cells highly 
expressing surface CXCR5, PD-1 and ICOS in the peripheral blood of a 
proportion of patients with SLE or Sjögren's syndrome is commonly used as a 
positive association to T-dependent humoral autoimmunity [289-291]. Notably, 
in mouse and human studies however, not all cases of self-reactive B cell 
responses receive nor require T cell help [292, 293]. To date, RC3H1 mutations 
in SLE patients have not been documented. This is possibly, in part, due to 
compensatory tolerogenic activity of RNA-regulating analogues like RC3H2 and 
ZC3H12A, encoding for ROQUIN2 and REGNASE-1, respectively.  
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Of particular interest to this thesis is the therapeutic implications of ROQUIN-
AMPK signalling in Tfh-mediated immune disorders. Aspirin, Metformin and the 
anti-cancer drug Methotrexate are clinically used medications that induce AMPK 
[294]. The effects of Metformin in particular on T cell AMPK in vivo and in vitro 
have been well-studied. In various lupus-prone mouse strains, including 
NZB/NZW and a Sle1.Sle2.Sle2 triple congenic strain, combined treatment with 
Metformin and 2-deoxy-D-glucose, an inhibitor of cellular glycolysis, was shown 
to significantly ameliorate autoantibody titres and aberrant PD-1highCXCR5high 
Tfh cell accumulation. These changes were associated with an increased 
frequency of FOXP3+ Tfr cells at the expense of FOXP3! Tfh cells and reduced 
CD4+ T cell expression of CD98, CD71, phosphorylated rS6, which are all 
indicative of dampened mTOR function [295]. 
 
In other studies of non-Tfh effector cells, experimental administration of 
Metformin into animal models of T cell-mediated autoimmunity results in a 
decline of pathogenic CD4+ T cell effector subsets, including Th1 and Th17 cells 
[296, 297]. The immunosuppresive functions of Metformin, particularly on 
autoreactive [254, 255] or asmogenic [298] CD4+ T effector cell responses, are 
tightly associated with an increase in Treg cells, an effect paralled by mTOR 
inhibition by Rapamycin treatment of CD4+ T cells in vitro and in vivo [299, 300]. 
 
Successful use of Rapamycin to treat human SLE patients was first reported by 
Fernandez et al. [241] in 2006, and was largely prompted by positive results of 
significant disease rescue when Rapamycin was administered to autoimmune-
prone MRL-lpr mice [301]. Given the findings in this thesis, which support the 
multitude of recent independent studies that mechanistically link AMPK and 
 129 
mTOR activity in T cell responses (section 5.1.), and the complementary 
immunosuppresive functions of Metformin and Rapamycin, particularly on 
mouse T cell-driven immunopathologies, it is worth considering the feasibility of 
co-opting the common therapeutic use of Metformin in mitigating type 2 
diabetes [302], to improve the outlook for patients with T cell-mediated 
autoimmune disorders. It is important to note, however, that Metformin can also 
elicit AMPK-independent growth and glycolytic signals in T cells [303]. 
 
Although our findings in this thesis show that T cell AMPK hyperactivity, at least 
in the abence of ROQUIN RING attenuation, does not contribute to pathogenic 
Tfh-GC reactions in vivo, there may be significant drawbacks with chronic 
Metformin high-dosage. Although not known to be linked to excessive AMPK 
signalling, adverse effects associated with Metformin administration include  
gastrointestinal discomfort leading to diarrhea, and dietary vitamin B12 
malabsorption [302]; the latter being completely reversible by oral intake of 
calcium supplements [304].  
 
6.5. Future directions 
Identification of direct trans-ubiquitination targets of ROQUIN E3 ligase activity 
could provide clarity into the immunomodulatory role of ROQUIN RING activity 
in T cells, with potential in identifying novel signalling molecules that 
preferentially coordinate Tfh cell lineage commitment. Characterisation of 
intracellular signalling pathways exclusive to Tfh cell control could reveal 
promising therapeutic targets specific for T cell-mediated immune diseases, 
and/or improve vaccine strategies to generate protective T cell-dependent 
memory B cells. 
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Identification of T cell immunometabolic regulators AMPK and mTOR in this 
thesis suggests that Tfh cell-specific metabolic pathways may be essential for 
the intracellular conversion of nutrient macromolecules and cofactors into 
bioenergenic reservoirs to facilitate specialised Tfh cell growth and effector 
functions. Is the metabolic profile of Tfh cells: (i) static throughout a GC 
response? (ii) essential to its role in GC induction, maintenance and selection? 
(iii) targetable and reprogrammable by pharmacological treatment to 
significantly drive T cell immune functional change? A potential logistical 
restriction in metabolomic screens of Tfh cells is the difficulty in collection of 
sufficient sample amount given the rarity of Tfh cell numbers in vivo, especially 
of specific Tfh cell subsets such as FOXP3+ Tfr cells. 
 
AMPK can act as an signal-transducing adaptor for fluctuations in nutrient 
levels and bioenergetic shifts, such as glutamine and glucose in T cells [238], 
and adenosine [199]. This is similarly the case for the sensitivity of mTOR 
kinase towards amino acid availability [222]. However, other than TCR-
mediated MALT1 proteolytic cleavage [110], upstream growth or other stimuli 
that modulate ROQUIN activity remain unkown. Future work may be required to 
determine if ROQUIN RNA-binding or covalently-bound post-translational 
modifications act as mechanisms of controlling ROQUIN. Although the ROQUIN 
protein in T cells has been shown to be phosphorylated at various residues by 
unknown kinases [305], the fundamental triggers that coordinate its 
compartmentalised regulatory functions on mRNA versus AMPK remain 
unknown. 
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It is likely that any future functional studies of ROQUIN may need to 
discriminate between RING and ROQ domain contributions. Retrospective 
interpretation of previous findings in the literature, for instance, observations 
based on the use of complete ROQUIN knockout mice or cell samples, could 
include significant phenotypic markers or molecular effects caused, at least in 
part, by inadvertent RING deficiency. This may also be true for the amplification 
of RING signals in cells or transgenic mouse models over-expressing full-length 
ROQUIN. 
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